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The purpose of this dissertation was to gaIn a better understanding of the 
possible association between childhood leukemia and nuclear facilities by conducting 
a meta-analysis and by the use of spatial and temporal models with respect to 
Pickering Nuclear Generator (PNG) in Ontario, Canada. 
The meta-analysis was conducted to combine and statistically analyze the many 
studies of childhood leukemia in the vicinity of nuclear facilities. Our focus was on 
studies that calculated SMRs or SIRs for individual nuclear sites. Due to variability 
between studies in defining age and geographic zones, eight separate analyses were 
performed based on age and zone stratification levels. One hundred and forty-six sites 
were used in at least one analysis. Unadjusted models, fixed effects models, and random 
effects models were used for each of the eight analyses. Meta-rates greater than one were 
found in all models at all stratification levels. Further, statistical significance at 95% 
confidence intervals was often achieved. Within geographic zones (as established by the 
meta-analysis), the 0-9 age group experienced higher rates than the 0-25 age group. 
There does not appear to be publication bias in the meta-analysis. 
To better understand the temporal and spatial relationship between radiation from 
PNG and childhood leukemia, smoothed moving rates through time and a spatial model 
(Score Test of Lawson and Waller) were used that allowed for a more comprehensive 
description of disease patterns. No apparent relationship between childhood leukemia 
and PNG was detected. In the temporal analysis, moving SIRs remained near one for 
the entire time-period for the census subdivisions of Pickering and Ajax (which contain 
PNG). Zones based on distance from PNG were created for the spatial analysis. The 
IX 
highest rates were found in the innermost and outennost zones, with the highest 
population in the outer zones. No significant results were found with the Score Test of 
Lawson and Waller. 
x 
1. INTRODUCTION 
In response to the cluster of childhood leukemia reported near the Sellafield 
nuclear site in Great Britain in 1984 (1), there have been numerous studies assessing the 
possible risk of childhood leukemia due to irradiation from nuclear sites. Some studies 
have found positive associations, though few results have been significant. Although 
there is little doubt that exposure to radiation increases the risk of developing leukemia 
(2-5), there is disagreement on whether the amount of exposure received by children 
living near nuclear sites is sufficient to increase risk. The purpose of this dissertation is 
to gain a better understanding of the possible association between childhood leukemia 
and nuclear facilities by conducting a meta-analysis and by the use of spatial and 
temporal models with respect to Pickering Nuclear Generator in Ontario, Canada. 
Meta-analysis 
Determining individual exposure in proximity to nuclear sites is problematic. 
Parameters that need to be considered include, type of nuclear site, wind speed and 
direction, topography, facility emissions, and distance from the site. F or the child, 
parameters include age and lifestyle (i.e. whether the individual spends more time 
outdoors or indoors). Due to the difficulty of determining individual exposure levels, 
researchers have largely relied on identifying cases or deaths in a predefined area and 
calculating a standardized rate without a specific reference to exposure, instead, using 
geographic zones in proximity to the nuclear site as a surrogate for exposure. 
Within the multitude of studies, many type of inconsistencies in methodology 
have surfaced including: 
1 
• Age-The choice of age group to study has not only varied between 
studies in different countries, it has also varied between studies of a single 
nuclear site. This may reflect the uncertainties in detennining at which age 
a child is no longer more susceptible in developing leukemia than an adult. 
• Area-Past studies have used: 5 km, 10 km, 12.5 km, 16 km, 25 km, 35 
km, county, and even a single village. Since the selection of area is often 
arbitrary (defined by an area with available census data), the choice 
naturally lends itself to selection bias. Too small an area may 
underestimate risk to children living outside the area and too large an area 
may miss a slight increase in risk if that risk is found near the nuclear site 
and much of the study area is not in the actual exposure zone. 
• Time-interval-Duration of time analyzed varies greatly from study to 
study. The primary barrier is the length of time the site was operational 
and the availability of incidence/mortality data and population counts. 
• Endpoint-Incidence data is generally preferable to mortality data as 
incidence data includes the census area where the person lived at date of 
diagnosis. This is a better indicator of where the person may have resided 
at time of exposure. Mortality data, on the other hand, may more easily be 
affected by a migration bias. Survival rates have also increased for 
childhood leukemia making incidence a better indicator than mortality. 
2 
Another difficulty arises because childhood leukemia is a rare disease and nuclear 
sites are frequently found in sparsely populated areas leading to small sample sizes and, 
consequently, low power to detect small increases in risk. One method to increase 
sample size and power is to pool several cohorts that share common study characteristics 
and conduct a meta-analysis. 
Although there exists papers that summarize the many cohort and case-control 
studies on childhood leukemia in proximity to nuclear sites, as well as report other 
potential causes such as the possibility of an infectious origin associated with population 
mixing (6-7), there has not been an attempt to combine and statistically analyze these 
many studies, which is the purpose of this analysis. 
Spatial and Temporal Analysis of Pickering Nuclear Generator 
There have been several statistical methods used in cohort studies of childhood 
leukemia and nuclear facilities. The most common method is the standardized mortality 
rate (SMR) or standardized incidence rate (SIR). Generally the rate is calculated for the 
longest time frame that data is available, occasionally it is broken down into pre-defined 
time-intervals (i.e. 10 year intervals). The population studied is dependent on the 
geostatistical unit, on which census data is available for that region, ranging from county 
level to postal codes. The size of the census area is important. If the excess risk is only 
to those residing near the facility, including a large unexposed population may not allow 
detection of the excess risk; similarly, if the area of study is too small and the excess risk 
exceeds the study area, the study may lack the power to find a statistically significant 
excess (8-10). Another common method used in the cohort studies is to choose control 
3 
areas that have similar census characteristics to the area under investigation, and calculate 
a relative risk. A third, and rarely used method, spatial analysis, considers distance from 
the source when detennining exposure and consequently, risk. 
Canadian researchers conducted two studies to analyze childhood leukemia in the 
vicinity of nuclear facilities in Canada; Phase I included the 0-4 age group (11) and Phase 
II analyzed the 0-14 age group (12). Nuclear facilities were categorized into one of three 
groups: nuclear research and development facilities, uranium mining, milling and refining 
facilities, or nuclear generating stations. For SMRs, the researchers looked at residence 
at birth and residence at death; and for SIRs, only residence at birth was used. No 
statistically significant increases in childhood leukemia at the alpha=0.05 level of 
significance were found; however, the Phase II study's pooled mortality analysis for the 
population living "nearby" «25 km) to two nuclear generating stations, Pickering 
Nuclear Generator (PNG) and Douglas Point Nuclear Generator had an SMR of 1.4 with 
a lower confidence band of 0.98 when using residence at birth. Further, each generator 
had a non-significant SIR greater than one, suggesting that more research was needed+ 
Although the researchers would have preferred to use a smaller area than <25 km for the 
nearby population, they were not able to do so due to the sparse population found near 
most of the nuclear facilities; and at the time of the study, census subdivision was the 
smallest geostatistical unit available for census data. F or most facilities, the census 
subdivision in which the site was located was close to the 25 km radius. However, PNG 
is located near Toronto, in an area more densely populated than other Canadian nuclear 
facilities. Six census subdivisions were included in the <25 km area (Figure 1.1). The 
majority of the population in the PNG area is found in Scarborough, a district of Toronto 
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located west of PNG. If exposure were related to prevailing wind direction, one would 
expect the largest risk would be to children living northeast of PNG; therefore, including 
the population of Scarborough would lessen the power to find an increased risk due to 
PNG. Conversely, if childhood leukemia was positively correlated with population 
density and radiation from PNG was too low to affect leukemia rates, including 
Scarborough would increase the probability of a Type I error when the primary 
hypothesis is testing radiation from PNG as the risk factor. 












Another potential issue is the use of a two-sided statistical test. Choosing whether 
to use a one-sided or two-sided test must be considered carefully. If one is certain that the 
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exposure in question may only be harmful or have no effect at all, then choosing a one-
sided test is plausible. If Clarke selected a one-sided test, the SMR for the nuclear 
generating stations would have been significant. 
The nuclear generating stations of Canada are pressurized heavy water reactors 
(13). Pressurized heavy water reactors produce greater amounts of tritium than the more 
commonly used pressurized (light) water reactors and boiling water reactors per unit 
power production (14,4). Tritium presents many challenges to the scientific community. 
In the gas form, tritium may diffuse through most any container and is difficult to detect 
in its oxide form. It may also bond to any molecule that contains hydrogen. Although 
tritium occurs naturally in the environment, little is known about the impact of low-level 
tritium exposure (14). Grosche hypothesized that the excess cases of childhood leukemia 
near the Kruemmel nuclear power station in Germany may be either directly or indirectly 
related to tritium release from the facility. The researchers compared local childhood 
leukemia rates to the amount of tritium release from Kruemmel and the Savannah River 
Site, a weapons facility that produced plutonium and tritium in the United States. 
Although Savannah River Site released greater amounts of tritium than Kruemmel, 
increased rates of childhood leukemia were only found near Kruemmel (15). One 
disadvantage in comparing Kruemmel and Savannah River Site is that Kruemmel is 
located near a town and Savannah River Site is located in a rural area. Further, cases and 
deaths near Savannah River Site may only be analyzed at the county level, possibly too 
large an area to detect a small increased risk near the facility. 
The advantages of studying PNG include: 
• PNG is a pressurized heavy water reactor that produces tritium. 
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• PNG is located near a large urban area and has the advantages associated 
with large sample sizes, in particular greater power to detect a smaller 
increased risk. 
• Ontario's cancer registry began in 1964. 
• Ontario population and cancer registration data is available at levels 
smaller than counties, including census subdivisions and enumeration 
areas. 
Since much of the data used in this analysis overlaps the data used by Clarke, the 
purpose of our research is exploratory and designed to better understand the temporal and 
spatial relationship, if any, of childhood leukemia and PNG. 
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2. REVIEW OF LITERATURE 
In 1983, a British television reporter visited the Sellafield nuclear site in West 
Cumbria, England. The reporter's purpose was to make a documentary on the health of 
the Sellafield workers with respect to radiation exposure. \-\-'bile visiting the site, the 
reporter learned from the local residents that there might be an excess of childhood 
leukemia in the village of Seascale located 3 km to the south. After investigating the 
residents claim, the reporter aired the program suggesting a ten-fold increase in childhood 
leukemia in Seascale; and alleged that the cases were linked to the nuclear facility's 
release of radioactive liquids into the Irish Sea, leading to contaminated beaches and 
seafood. The British government established an independent investigation led by Sir 
Richard Black to further investigate the reporter's claims (16). The following year, the 
Black report confirmed the excess cases of leukemia in the 0-24 age group in Sellafield 
and stated the excess was highly statistically significant (1). Since the Black report, 
epidemiologic studies around the world have been undertaken to analyze the risk of 
leukemia to children living near nuclear facilities. Following is a summary of descriptive 
studies by nation and a list of potential risk factors (many studies are represented in 
tabular form in Appendix B). 
Studies by Nation 
Great Britain (England & Wales) 
Prior to the Black report, Baron examined the temporal change in cancer rates in 
counties containing fourteen nuclear facilities in England and Wales (including 
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Sellafield). He concluded there was no significant increased risk of cancer (including 
childhood leukemia) in these counties. Baron, aware of the unpublished results of the 
Black report, stated the contrast to the Black report is due to the size of the area chosen-
Baron used county level data, while the Black report concentrated on a much smaller area 
around Sellafield (1 7). 
In 1987, researchers found a significant excess of childhood leukemia (age range 
0-14) within the overlapping 10 km radii of two nuclear facilities, Aldermaston and 
Burghfield. The excess was primarily attributed to the 0-4 year olds (18). Another study, 
this one focusing on Hinkley Point nuclear power station (0-24 year olds), found a 
statistically significant excess of leukemia and non-Hodgkin's lymphoma with most of 
the excess attributed to the first ten years after the facility began operation (19). 
A 1987 study of 14 nuclear sites in England and Wales (age 0-24), using control 
areas to determine relative risk, reported a statistically significant relative risk of 2.0 for 
all nuclear sites combined (20). Two years later, a similar study of 15 nuclear facilities in 
England and Wales (age 0-24) found a relative risk of 1.15 (p=O.OI) for all facilities 
combined (21). However, the researchers also found a statistically significant relative 
risk of 1.4 in areas that were considered by the British government as possible sites for 
nuclear installations (22). 
In 1992, a study was published that investigated the areas around 21 nuclear sites 
and restricted the age group to 0-9 years of age. The study used two methods: 1) 
Expected cases calculated using regional data-since regional data have a much larger 
population at risk in the denominator, the Poisson distribution was used to determine risk. 
2) Expected cases based on comparison areas with approximately the same population 
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size-since population at risk is equal, the Binomial distribution was used to determine 
risk. Using childhood leukemia incidence data, Sellafield was significant under the 
Binomial distribution (p=O.029), Aldermaston was significant using the Poisson 
distribution (p=O.020); only the Amersham facility indicated statistically significant 
results for both methods. Further, only Amersham showed a significant excess of 
childhood leukemia when examining mortality data (Binomial, p=O.0054) (23). 
In 1993, a study was published that re-examined Sellafield from 1963-83 and 
added data for the years 1984-90. The data used the 0-24 age group and both leukemia 
and non-Hodgkin's lymphoma. The combined data continued to indicate a significant 
excess of cases. Although the 1984-90 data introduced only two new cases, the 1984-90 
time-period produced a statistically significant excess of cases (p=0.007) (24). The 
Committee on Medical Aspects of Radiation in the Environment (COMARE) used data 
through 1992 to show that the excess persisted (25,7). 
In 1994, a study looked at 29 sites in England and Wales. The researchers used 
tests that would be more sensitive to the spatial patterns of the disease (known as focused 
cluster tests). Only the areas around Sellafield (p=O.00002) and Burghfield (p=O.031) 
showed an excess of leukemia and non-Hodgkin's lymphoma in the 0-14 age group (9). 
In 1997, Busby and Cato examined seven districts in the vicinity of Aldennaston 
and Burghfield nuclear sites. The researchers used leukemia mortality data for the 0-14 
age group. The highest relative risks were found in the two districts that COMARE 
detennined would be most affected by radiation, South Oxfordshire (R.R.=2.4S, 
p=O.0047) and Newbury (R.R.=1.93, p=O.031) (26). The same year, Draper looked at 
leukemia incidence data for the 0-9 age group in the same seven districts. The study also 
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presented incidence rates for all districts in England, Wales, and Scotland. The authors 
concluded that the incidence rates in the two districts that Busby and Cato found elevated 
rates, were not unusually higher than the adjacent districts (27). 
Great Britain (Scotland) 
A study was undertaken by COMARE to evaluate leukemia in the area that 
contains the Dounreay nuclear installation. The study looked at people aged 0-24 in three 
non-overlapping time-periods (1968-73, 1974-78, and 1979-84) and two categories of 
distance of residence from the facility «12.5 km and 12.5 to < 25 km). Five cases were 
observed in the time-period 1979-84 and the distance category <12.5 km while 0.513 
cases were expected (p=O.OO 1). No other significant results were found (8,28). Eight 
years later, another study was published that included additional incidence data for 1985-
91. The author combined the time-periods and used only the distance, <25 km. Twelve 
cases were observed and 5.2 were expected (p=O.007). In the latest period, 1985 .... 91, four 
cases were observed and 1.4 expected (p=O.059) (29) 
In 1996, incidence of leukemia and non-Hodgkin's lymphoma in children 
between 0-14 years of age residing near seven nuclear sites was analyzed with a focused 
cluster test, the authors reported that the increase reported previously near Dounreay 
showed a significant result (p=0.030) when considering distance (30). 
France 
The first French study to examine cancer around nuclear sites was published in 
1989 and focused on mortality in the area of the La Hague nuclear facility. The study 
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used a zone of 10 km. There was no excess found for any cancer (31). A year later, 
researchers looked at the La Hague site exclusively for mortality from childhood 
leukemia. Again, no excess, was found (32). The first study near La Hague to use 
incidence data for leukemia in young persons (age group 0-24) was published in 1993. 
The time-period used was 1978-90 and case ascertainment was done without a cancer 
registry. Although a standard incidence ratio (SIR) of 2.5 was found, it was not 
significant (33). Another La Hague study was published in 1995 .. Three statistical tests 
were examined that are designed to detect the presence of clusters around a putative 
source. The first, a conventional test examining incidence rates for subregions and 
searching for patterns; the second is a focused cluster test known as Stone's Test; and the 
third, extraction mapping techniques based on kernel regression smoothing. The results 
were close to significant when using Stone's Test (p=O.06); the other tests were further 
from significant (34). The latest study reported no new cases of leukemia between 1993-
96 (7,35). 
Bouges investigated the relationship of childhood hematological cancers and the 
French Marcoule nuclear reprocessing facility using traditional SIRs and Bayesian 
methods. No significant increases in disease were found (36). 
Two multi-site studies took place in 1992 and 1995. Standard mortality rates 
were calculated but no significant increase was found (37-38). 
Germany 
A multi-site study was published in 1992 that looked at areas containing 20 
nuclear facilities throughout Germany. There were three distance groups considered (5 
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km, 10 km, and 15 Ian radii) (39). Similar to Cook-Mozaffari (21), incidence in areas 
containing nuclear facilities were compared with incidence in control areas. Increased 
risk of acute leukemia was found in the 0-4 age group at 15 km (p=0.037) and 5 km 
(p=O.015) radii, as well as increased risk of non-Hodgkin's lymphoma at 15 Ian 
(p=O.017) and 10 km (p=0.OI2) radii. The results were for all sites combined-
individual sites were not considered. The results may have reflected the unexpected low 
incidence rates in the control areas (39). Between February 1990 and May 1991, six years 
after the start-up of the Kruemmel nuclear power generator, five cases of leukemia were 
found in the rural community of Elbmarsch, within a five km radius of the Kruemmel site 
and on the opposite side of the river. A sixth case was diagnosed in 1995. Although 80% 
of the population lives north of the site, five of the sixth cases lived south of the site (the 
sixth case had moved from the south region to the north region a few months before 
diagnosis). The SIR for 1990-1995 was 460 (95 % CI: 210, 1,030) (40). Between 1994 
and 1996, four more cases of childhood leukemia were found in proximity to Kruemmel 
(15). 
United States 
The earliest epidemiology studies of the general population near nuclear facilities 
began in 1949. Tokuhata and Smith give a brief summary of the 1949 study as well as 10 
other similar studies that were conducted before 1978. The overall conclusion was that 
the rates of cancers, infant mortality and birth defects were similar to the general 
population or control areas (41). A national study was conducted in 1991 that looked at 
counties that contained a nuclear facility or that was near one of 62 nuclear sites. Each 
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county was compared to three control counties. Mortality data for all cancers, leukemia 
(all ages), and childhood leukemia from 1950-1984 was used. Incidence data was also 
used for the few sites that were in areas with cancer registries. There was no overall 
excess found. The author concludes, "If any excess cancer risk was present in US 
counties with nuclear facilities, it was too small to be detected with the methods 
employed" (42). 
Grosche compared the Kruemmel site in Germany to the Savannah River Site in 
South Carolina, both sites release tritium into the environment. Although tritium releases 
from the Savannah facility were several orders of magnitude higher than the Kruemmel 
site, there was not an excess of leukemia cases near the Savannah site between 1991 and 
1995. Tritium release from Kruemmel is primarily airborne while tritium release from 
the Savannah facility is primarily through water (15). 
A 2003 study by Boice examined two former nuclear materials processIng 
facilities in Western Pennsylvania. Using a method similar to Jablon, no significant 
results were found before, during, or after the facilities closed (43). 
Mangano studied counties near nuclear reactors in the eastern United States. 
Statistically significant elevated incidence of childhood leukemia was found in the 0-10 
age group (44). 
Canada 
Canadian researchers studied areas around five nuclear facilities in Ontario: an 
atomic energy research and development facility, a uranium refinery, a uranium mining 
and milling facility, and two nuclear power. Incidence and mortality data was available 
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through the Ontario Cancer Registry. Birth certificates and death certificates were also 
ascertained for leukemia cases in children between 0-14 years of age. The main objective 
was to "investigate whether the frequency of leukemia among children born to mothers 
residing in the vicinity of nuclear facilities differed from the provincial average." A 
secondary objective was to determine, where possible, if rates for leukemia was different 
before and after a facility opened. Census subdivisions within a radius of 25 km from the 
nuclear facilities were used in the analysis. The pooled SMR, by residence at birth, in the 
25 km radius around Pickering Nuclear Generator (PNG) and Douglas Point Nuclear 
Generator was 1.40 (95% CI: 0.98, 1.9) for all birth cohorts combined. The SIR, by 
residence at birth, in the same area was 1.15 (95% CI: 0.90, 1.44). The SMR, by 
residence at birth, in the 25 km radius before Pickering was in operation was lower 
(SMR 1.08; 95% CI: 0.86, 1.34) than after the facility began operation (SMR=1.34; 95% 
CI: 0.92, 1.89). Douglas Point Nuclear Generator and the uranium refinery also showed 
increase risk but the lower confidence bands were well below one. Due to the low 
population density in the Douglas Point and uranium refinery areas, the increased risk 
would need to be very large for a significant result (45,11-12). 
Other Countries 
Researchers in Japan conducted a national study where the municipalities around 
several nuclear sites were examined for mortality from leukemia in the 0-14 age group. 
Between the years of 1973 and 1987, there was no overall excess risk when compared to 
control municipalities (46~7). 
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Waller used several methods of cluster analysis to identify if there was an excess 
of leukemia in children 0-14 years of age near four nuclear facilities in Sweden. Between 
1980 and 1990, no significant clusters were found (47). 
Researchers looked for spatial and temporal trends in the Negev region of Israel, 
where a nuclear facility is located. Although childhood leukemia rates (age: 0-9) were 
consistently higher over time in Western Negev (as compared to Eastern Negev), no 
excess cases were found in the towns near the facility (48). 
A Spanish study looked at seven nuclear power generators and five nuclear fuel 
facilities during the period 1975-93. Using towns lying between 50-100 km from the 
facilities as controls, no excess mortality was found near the nuclear power generators. 
However, one uranium-processing facility in Anujar (R.R.= 1.30; 95% CI: 1.03, 1.64) 
found a significant excess of mortality from leukemia; and the uranium-processing 
facility in: Cuidad Rodrigo (R.R.= 1.68; 95% CI: 0.92,3.08) found a slightly non-
significant increase in mortality. Excess risk of mortality from multiple myeloma was 
found in the area of the Zorita nuclear power generator Lopez-Abente, Aragones, et a1. 
1999 (49). 
Zaridze examined former nuclear weapons test sites in Kazakhstan (formerly of 
the Soviet ·Union). Increased rates of childhood leukemia were found for children living 
within 200 kilometers of the former test areas when compared to children living more 
than 400 kilometers from the areas (50). 
In response to the 1986 accident at Chemobyl located in Ukraine, studies from 
neighboring countries have been conducted, including Hungary (51) and Belarus (52). 
No increased rates of childhood leukemia were reported. 
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Large Geographical Studies 
According to Dockerty, over 30 studies from around the world have examined 
whether there is large scale spatial and lor temporal clustering of childhood leukemia. Of 
the 33 known datasets (including Dockerty's New Zealand dataset), 15 indicated 
statistically significant evidence of clustering, 13 presented no evidence of clustering, and 
five found possible clustering in one to several subgroups (53-63). 
A 1993 study by Alexander lists several small clusters that have been reported as 
early as 1930 (56). 
The largest study to determine whether childhood leukemia show a general tendency 
to cluster was the EUROCLUS project. Between 1980 and 1989, EUROCLUS collected 
incidence data for 13,551 cases of childhood leukemia in seventeen European countries. 
The key findings in the 1998 EUROCLUS report include: 
• Childhood leukemia does not show strong spatial clustering; however, statistically 
significant results of spatial clustering were found but of small magnitude. 
• Clustering focused in areas of intermediate population density (150-500 
personslkm2) 
• Compared to control areas, cluster areas have demographic characteristics that 
indicate: isolation (initially) and popUlation mixing possibly indicating an 




Paternal preconceptional exposure 
Gardner conducted a case-control study with 52 cases (age: 0-25) ofleukemia~ 22 
of non-Hodgkin·s lymphoma~ and 23 of Hodgkin's disease occurring in people born near 
Sellafield and diagnosed in the area in 1950-85 and 1001 controls matched for sex and 
date of birth taken from the same birth registers as the cases. For those leukemia cases 
born within 5 km of Sellafield, the statistically significant relative risk was 2.44. For 
children of fathers employed at Sellafield at the time of conception and who received 
greater than 100 mSv of radiation, the statistically significant relative risk for leukemia 
was 6.42. The idea that paternal preconceptional exposure can cause leukemia In 
offspring became known as the Gardner hypothesis. However, eating seafood or 
homegrown vegetables or playing on the beach did not increase risk (65-66). 
The concept that paternal preconceptional exposure can cause lethal mutations 
goes back to at least 1927, when Muller conducted a study of the common fruit fly (67). 
Mouse studies indicate that it would take an acute dose of 1,500-3,000 mSv (15-20 times 
the accumulated dose of the most heavily exposed Sellafield workers) for "spermatozoa 
or spermatogonia to double the spontaneous rate of a wide range of single gene defects" 
(68). However, germline mutations in humans (due to an environmental exposure) are 
more difficult to investigate (68-69). 
One difficulty in human studies is to accurately account for all radiation that 
nuclear workers are exposed to and where in the body the radionuclides accumulate. 
Although the Sellafield workers wore external monitoring badges, it may be possible for 
internal contamination of radio nuclides to be greater than that recorded on the film badge. 
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An increased risk of more than IO-fold (similar in size to the Black report (1)) was seen 
for prostatic cancer in workers of the United Kingdom Atomic Energy Authority and the 
Atomic Weapons Establishment who had at least 100 mSv of radiation recorded on their 
film badges. These workers also were monitored for possible internal contamination and 
it was suggested that some radionuclides might be concentrated in the prostate (70-72). 
The atomic bomb data contains 7400 children of Japanese men that survived the 
bomb; there was no increased risk of leukemia in the offspring (73-74). It should be 
noted that atomic bomb survivors received a single high-level dose of radiation; whereas, 
the nuclear industry workers receive chronic fractionated low-doses of radiation. Greaves 
suggest that if a gennline mutation is responsible then we could expect to see an increase 
in fetal death, other pediatric cancers, and congenital malformations. These should be 
more common than the leukemias since they can arise from a single dominant mutation; 
unlike acute leukemia in children, which most likely requires at least two independent 
mutations (75-76). 
Roman conducted a case-control study of leukemia and non-Hodgkin's 
lymphoma near Aldermaston and Burghfield atomic weapon establishments. Of the 
cases and controls with fathers who wore film badges, a slightly significant relative risk 
of9.0 (CI: 1.0, 107.8) was found. However, the authors caution that the small number of 
cases, three, are not enough to discount chance (77). 
McKinney performed a case-control study in three areas of Great Britain that had 
recently reported clusters of childhood leukemia (not including Seascale). Although odds 
ratio for preconceptional exposure of fathers to ionizing radiation was increased (but not 
significant), there were significant associations to the fathers' exposed to wood dust 
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(O.R.=2.73; 95% CI: 1.44,5.16), all types of radiation (O.R.=3.23; 95% CI: 1.36,7.72), 
and benzene (O.R.=S.81; 95% CI: 1.67, 26.44) (78). 
Parker conducted a cohort study consisting of 10,363 children born in West 
Cumbria to fathers employed at Sellafield between 1950-89 and concluded that the there 
was no increase in leukemia in other villages near Seascale, where many of the workers 
lived; therefore, they could not find evidence to support the Gardner hypothesis (79). 
Draper conducted a case-control study that included 35,949 children diagnosed 
with cancer and matched controls. Fathers of children with leukemia and non-Hodgkin's 
lymphoma were significantly more likely than fathers of controls to have been radiation 
workers (R.R.=1.77; CI: 1.05,3.03) and a significant five-fold increase in relative risk for 
children of female workers (R.R.=S.OO; CI: 1.42, 26.94); however, there was no dose-
response relation for any of the exposure periods studied. The authors concluded that the 
Gardner hypothesis was not supported (80). A case-control study of children with 
leukemia (or non-Hodgkin's lymphoma), living near the Dounreay facility (Scotland), 
failed to find evidence to support the Gardner hypothesis (81). Nor did the 1993 
Canadian case-control study, conducted by McLaughlin, find evidence to support the 
Gardner hypothesis (82). 
Infectious Agent 
The idea that leukemia can be caused by an infectious agent is not new. Many 
animal leukemia's are caused by viruses (83). There are also examples of viruses 
associated with hematological diseases in humans. The list includes Epstein Barr virus 
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with Burkett lymphoma and human T-cell lymphotrophic virus type 1 with adult T-cell 
leukemia (7,84-85). 
In 1988, Kinlen hypothesized that "childhood leukemia may be a rare response to 
an unidentified mild or subclinical infection, the transmission of which is facilitated when 
large numbers of people come together, particularly from a variety of origins." The idea 
is that herd immunity to a possible widespread viral infection would tend to be lower than 
average in isolated areas. The study looked at an area in Scotland that was rural until an 
influx of people in the 19508. The area received the population growth at the same time 
as the area around the Dounreay nuclear facility (which was also rural), where an 
increased risk of childhood leukemia was found. Similar to the area around Dounreay, a 
significant increase of leukemia below age 25 was found (10 observed, expected 3.6), 
with a greater excess below age 5 (7 observed, 1.5 expected) (6). More evidence for the 
Kinlen hypothesis was presented in 1990 when Kinlen, studied fourteen British "New 
Towns." Nine of the New Towns were built in response to wartime air raids and 
maintenance neglect in London. Congestion and housing conditions were poor and the 
New Towns were to provide housing and jobs to those dispersed from London. The New 
Towns were built close to the city and attracted a "well-mixed" group from the city. Five 
"rural" New Towns were created to increase population near industrial development 
areas. The incomers to these towns had a wider variety of origins than the overspill nine 
New Towns. The study was categorized into two time periods (1945-64 and 1965-85). 
There was a significant excess of leukemia, for the 0-4 years old, in four of the rural New 
Towns during the first time period. No excess was found in the people age 5-24 in either 
period. Nor was there excess in any of the nine overspill New Towns. Although the 
21 
cases were not confined to a single cell type, the only significant excess was in acute 
lymphatic leukemia (86). 
The Kinlen hypothesis has been supported in several studies. In 1949-50, British 
servicemen were concentrated in densely populated rural military camps. A significant 
excess of childhood leukemia was evident (87). During 1969-73, local authority areas in 
England and Wales that had a population increase of more than 50% also experienced an 
excess of childhood leukemia. These excesses were mostly in rural areas (88). 
Construction workers of the North Sea oil terminals, who would work and live in a 
worker's camp for four weeks and then go to their homes for one week, were studied. 
Excess cases were found in the rural areas where many of the "oil" workers lived (89). 
Also in Britain, an excess of cases were found in the rapidly growing residential areas 
where many people would live and then commute to work in another town (90). During 
World War II, Britain evacuated large numbers. of children to rural areas. A study was 
conducted to look at leukemia in the rural areas for the period 1945-49. The areas were 
categorized by increasing proportion of evacuees and a significant positive trend was 
found (91). Childhood leukemia and non-Hodgkin's lymphoma near large rural 
construction sites in Britain were compared to the Sellafield nuclear site. A 37% increase 
in leukemia and non-Hodgkin's lymphoma (age 0-14) was recorded during construction 
and the following year. There was a 72% increase in cases during the time when 
construction workers and operating staff overlapped, particularly in areas of high social 
class (92). 
Italy and Greece had very high levels of rural migration in the 19508 and 1960s. 
During this time, both countries also had unusually high mortality rates from childhood 
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leukemia. Researchers suggest that the rural population mixing may have contributed to 
the excess mortality (93). The EUROCLUS project also suggests an infectious aetiology 
(63-64), as well as a study similar in methodology to Kinlen carried out in Canada (94). 
Despite the fact that no possible infectious agent has been identified, several 
hypotheses have emerged to explain the transmission route. These ideas are based on the 
collective studies that suggest the childhood peak of leukemia (mainly ALL) appear at 
ages two to four years at different times this century yet still do not appear in developing 
countries (7). Greaves suggests that the "peak has been produced by socioeconomic 
improvements which have resulted in the delay of exposure to infections from infancy 
until the ages represented in the childhood peak, when lymphocytes may be more 
vulnerable to spontaneous mutations" (95). Smith focused on the infection history of 
women of childbearing age. The researchers hypothesized "that under the improved 
hygiene conditions that occur with increased socioeconomic status, more women of 
childbearing age are likely to be unexposed to a putative leukemia-inducing .agent(s), 
leading to increased opportunity for in utero transmission due to primary infections 
during pregnancy or leading to a higher frequency of infections during early infancy due 
to the absence of protective maternal antibodies, and consequently resulting in more 
children at risk for developing ALL" (96). After the Smith paper, Naumberg reported an 
association between exposure to maternal lower genital tract infection in utero, and risk 
of developing childhood leukemia (97). 
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Environmental exposure to ionizing radiation from man-made sources 
Exposure from ionizing radiation to prenatal individuals is a recognized risk 
factor for cancer (98-100). Studies have also shown that postnatal exposure to nuclear 
workers (101-102), individuals treated by radiotherapy (4), and atomic bomb survivors 
(5) can lead to leukemia. The Life Span Study (LSS) of atomic bomb survivors also 
recognized an increased risk of leukemia in young people (age 0-24) with a relatively 
short latency period (7,5). However, there has been a debate whether the amount of 
radiation released into the environment has been enough to cause the excess of childhood 
cancers that have been reported in proximity to nuclear facilities. 
Case-control studies have been conducted near Sellafield (66), Dounreay (81), 
and La Hague (103) nuclear facilities to determine risk from environmental 
contamination. The Sellafield study was unable to find increased risk from eating 
seafood or visits to the beach (66). The Dounreay study reports a statistically significant 
increased risk for use of the beach within 25 km of the facility (p<O.04). The authors did 
caution that the results were based on small numbers, multiple hypothesis testing, and 
possible systematic bias (81)~ Near La Hague, increased trends were found for use of 
local beaches by mothers and children (p<O.Ol), consumption of local seafood (p<O.OI), 
and a relative risk of 1.18 (95% CI: 1.03, 1.42) for length of residence in a granite-built 
house (103). Although case-control studies such as these may raise questions about 
possible risk of leukemia from environmental contamination, at best, they provide only 
indirect evidence. Stronger evidence would come from studies designed to determine a 
dose-response relationship (7). 
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Several studies have attempted to reconstruct the doses of ionizing radiation to the 
population living near nuclear facilities and to determine risk of cancer associated with 
the radiation. Unlike the studies that use distance as a surrogate to actual dose estimates 
(usually by classifying exposure zones as a fixed radius around a putative source), dose-
response studies use mathematical models to adjust for temperature, wind, terrain, etc. 
allowing for different distribution of radioactive emissions across areas at similar 
distances from the source (104). Expected cases must be detennined from dose-response 
relationships found in other studies. Studies used in the past include: the Life Span 
Study (105), the British ankylosing spondylitis patients treated with high doses of x-rays 
(106), and the Oxford Survey of Childhood Cancers (107). In the Life Span Study 
(adults versus children below the age of 5 years), it has been calculated that for a given 
dose of radiation, the relative risk for leukemia increases with younger age by a factor of 
4-5 (40,105). For prenatal exposure, a factor of approximately 70 can be derived from 
the data of the Oxford Survey of Childhood Cancers (40,107). 
Unfortunately, many of the dose-response studies near nuclear facilities were 
published as technical reports, not readily attainable (1,8,108-118). However, Goldsmith 
(23) and Laurier (7) have presented summaries of the results of several of these studies. 
The studies consistently found that the doses attributable to nuclear facility waste 
discharge were not high enough to account for the excess cases of hematologic cancers 
found in those areas. For example, estimated doses from the Sellafield facility were 40 
times to 300 times lower than would be needed to account for the excess cases (1,110). 
Near Dounreay, 'Ithe total risk of radiation induced leukemia in an estimated 4550 young 
people resident in the village of Thurso between 1950 and 1984 will have been well 
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below one case (0.34)" (8,112). However, six cases were found in Thurso during that 
time period (23). Excess cases of leukemia in children between the ages of 0-14 years of 
age, based on the estimated discharge from Aldermaston and Burghfield, is between 6 x 
10-5 and 6 x 10-4 (109). Furthennore, bone marrow dose attributable to waste discharge 
from the facilities (within 5 km radius) was at least 1,000 times lower than the dose due 
to natural exposure (115). 
There are disadvantages in determining excess risk from dose-response studies. 
For example, synergistic effects of mUltiple environmental exposures are not well 
understood. Gibson and Wheldon suggest synergistic effects between irradiation and 
chemical exposures may increase the potential of either factor to cause leukemia (40,119-
120). Furthermore, Hoffman believes exposure assessments in the dose-response studies 
completed to date are generally limited because "routine environmental radiation 
surveillance can fail to detect chronic exposures from short-lived f3-emitters or from 
extremely inhomogeneous spatiaVtemporal distributions of radionuclides. In fact, 
elevated rates of structural chromosomal aberrations in a casual sample of five parents of 
leukemia cases and four other adult Elbmarsch residents would be compatible with past 
releases of short-lived fission products, which might have been missed by routine 
surveillance (2.4 dicentric chromosomes/l,OOO metaphases observed, 0.4/1,000 expected 
p<O.OOOl)" (40). 
Other potential risk (actors 
There have been several studies that have identified other risk factors that have 
not been mentioned to this point. A list of the potential risk factors follows: 
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• Electromagnetic fields (121-124) 
• Pesticides (125-129) 
• Benzene (leukemia risk factor for all ages) (130) 
Methodological Inconsistencies 
Since many researchers and a large portion of the general population believe 
environmental contaminants (e.g. radiation, benzene, and pesticides) are a risk factor for 
several diseases including leukemia, childhood leukemia is often viewed as a marker for 
these environmental contaminants. Largely for this reason, clusters of childhood 
leukemias near nuclear facilities have become a "hot" topic that has lead to a multitude of 
studies. Within the multitude of studies, many types of bias and inconsistencies in 
methodology have surfaced: 
• Age-the choice of which age group to study has not only varied between studies 
in different countries, it has also varied between studies of a single nuclear site. 
For example, French studies have consistently analyzed people between 0-24 
years of age, German and Canadian studies have used the 0-14 age group, and 
British studies have chosen several age groups: 0-4, 0-9, 0-14, 0-24. The 
Sellafield studies alone have included the following age groups: 0-24 (as first 
published in the Black report (1)), 0-14, and 0-9. 
• Endpoint-The most common cancer endpoints are all leukemias, acute 
leukemias, acute lymphatic leukemia (ALL), and non-Hodgkin's disease. 
Significant results have been found for each above stated group of cancers and for 
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different combinations (ex. ALL + non-Hodgkin's disease). The only neoplasm 
that has been included in every study is ALL. Although ALL is included in all 
studies, many studies have not been able to report results alone for ALL. This is 
often the case for mortality studies because data differentiating between types of 
leukemias is either missing or unreliable. 
• Area-The choice of the area to study is arbitrary. Past choices have included: 5 
km, 10 km, 12.5 km, 16 km, 25 km, 35 km, county, and even a single village. 
Since the choice of area is arbitrary (defined by an area with available census 
data), the choice naturally lends itself to selection bias. Too large a study area 
may also lead to a loss of power for detecting localized effects if the effect to be 
detected is small. 
• When a single village is studied (ex. Seascale near Sellafield), they are usually 
chosen after a cluster has already been reported in the village.. This is often the 
case for the studies that "revisit" an area around a putative site. Therefore, "they 
have as their goal the verification of the existence of this excess, and not the 
evaluation of the probability of rejecting the null hypothesis. This could 
exaggerate the proportion of excess leukemia cases in these areas" (7). 
• Time-periods-Length of time studied varies greatly from study to study. The 
primary barrier is the availability of incidence/mortality data. 
• IncidencelMortality-Incidence data is generally preferable to mortality data 
because incidence data includes the address or census area where the person lived 
at date of diagnosis. This is a better indicator of where the person [may have] 
resided at time of exposure. Mortality data is more easily affected by a migration 
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bias. Incidence data also provides more confidence in detennining the histologic 
type of neoplasm. However, mortality data also has an advantage-because of 
the publicity generated by health effects and nuclear facilities, registration/case 
ascertainment bias has appeared in some areas. Cook-Mozaffari found evidence 
of more complete ascertainment near British nuclear sites than in control areas 
chosen for comparison (21). Alexander noted clear indications of better case 
ascertainment in the 5 km area around the Kruemmel nuclear site (Germany) 
compared to other areas: 42% of the cases in the 5 km area were reported by three 
or more institutions compared to 20% in the 5-10 km area and 29%, 25%, and 
31 % in distant areas (64). 
• Source of reference rates-The choice of reference rate effects the expected cases 
in an area. One must consider whether to use local or national rates and which 
covariates to include in determining the expected cases. 
• Lack of information on exposure level has made dose-response relationships 
nonexistent in most studies. 
Biology, Etiology, and US Incidence Rates 
Biology of Leukemia: 
Similar to many types of cancer, the leukemias can be defined by certain 
abnormal characteristics as described by (160): 
• Monoclonal origin 
• Acquired Gene Mutation 
• Genetic instability, clonal diversification, and progressive subclone selection 
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• Dysregulation or uncoupling of critical cellular functions: proliferation~ 
differentiation, and cell death 
• Net growth advantage, clonal dominance~ vascular and extravascular spread, 
and comprise of nonnal tissue functions. 
In leukemia, only one abnormal stem cell is necessary to lead to the disease. The 
suspect cell must experience the mutation or more likely sequential series of mutations. 
Over 100 genes have been identified that are candidates for mutations leading to certain 
leukemia subtypes. Approximately lOll blood cell divisions take place on a daily basis 
and when that is considered with respect to the probability of a gene mutation occurring 
in one cell cycle is 10-6 , it is likely that gene mutations are occurring all the time. 
However, most mutations are either functionally neutral for the cell or happen in non-
important cells. In fact, it is the rarest of mutations that is truly a candidate for 
proliferation. The mutation must happen in a hematopoietic cell with renewal capacity 
and the necessary gene must be altered in a certain sequence that confers net growth 
and/or survival advantage on the clonal descendants of the original cell. While most 
carcinomas appear to require 5 to 15 mutations that may take several years~ the leukemias 
may take only a few mutations~ and in extraordinary cases perhaps only one. Age 
differences exist when considering the probability of developing leukemia (Table 1.1). 
As an example, the lymphoid-restricted stem cells that can cause ALL, the dominant 
childhood leukemia, undergo extensive self-renewal early in life and therefore are at their 
most vulnerable. 
As described by the American Cancer Society, the four major types of leukemia 
are acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML) , chronic 
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lymphocytic leukemia (eLL), and chronic myelogenous leukemia (CML). For our 
purposes, acute can be defined as rapidly growing cells that do not mature properly. On 
the other hand, chronic is a condition where the cells live too long and cause a build-up of 
white blood cells. Lymphocytic leukemias originate from lymphocytes in the bone 
marrow and myelogenous leukemias originate from one of two types of white blood 
cells: granulocytes or monocytes. 
Etiology (161): 
Chronic leukemias: Radiation can induce CML but not CLL. According to the 
Life Span Study, rates of ALL, AML, and CML increased among Japanese exposed to 
the atomic bomb. However, CLL rates did not increase in the same population, nor has 
eLL rates increased in other irradiated populations. (162) The majority of the CML 
cases in the Life Span Study were developed 5-10 years after exposure and concentrated 
in persons under 45 years of age. It appears that ionizing radiation at doses greater than 
0.5 Grays may cause CML in humans. Although studies have found significant 
increases in acute leukemias in people exposed to certain chemicals, mainly benzene, the 
evidence does not support an increase in the chronic leukemias. Familial studies suggest 
that genetics play a larger role in the development of CLL than CML. Further, eLL 
patients are more likely to develop second cancers including melanomas, soft tissue 
sarcomas, and lung cancer. The excess of second cancers may be attributed to various 
reasons including genetic predisposition to other cancers, carcinogenic effects of 
treatment for CLL, or increased ascertainment due to medical attention for CLL. In the 
SEER popula~ion eLL incidence rates are less than 1 in 100,000 among persons under 
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age 50 and then quickly increase. For CML, one would expect between 1 and 2 In 
100,000 between ages 20 to 50 years and a slower rise than eLL after that. 
Acute leukemias: Studies have shown that radiation from nuclear reactions, 
occupational radiation, and therapeutic and diagnostic medical radiation can cause both 
ALL and AML. The use of certain chemotherapy agents has also been shown to cause 
AML, usually peaking 4-5 years after therapy. The only other chemical besides 
chemotherapy that has persuasive evidence that it may cause leukemia is benzene, mainly 
AML. Other positive associations have been found in petroleum refining, rubber 
manufacturing, and a slight increase in AML in smokers. However, these studies are 
only suggestive of a possible association. Familial studies have found that both ALL 
and AML may be caused by genetics. Acute leukemias can occur at all ages. Until age 
25, ALL is the dominant leukemia. ALL has a distinctive peak at about age 2-5; whereas 
AML begins to increase after age 50. 
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Table 1.1 - SEER Age-specific Incidence Rates, 1973-1991, per 100,000 (163) 
Age at 
Acute Acute Chronic Chronic 
Lymphatic Myeloid Lymphatic Myeloid 
Diagnosis 
Leukemia Leukemia Leukemia Leukemia 
0-4 5.7 0 .. 6 0.0 0.1 
5-9 3.1 0.4 0.0 0.1 
10-14 1.7 0.3 0.0 0.1 
15-19 1.2 0.5 0.0 0.2 
20-24 0.6 0.5 0.0 0.3 
25-29 0.5 0.7 0.0 0.4 
30-34 0.5 0.8 0.1 0.6 
35-39 0.5 1.1 0.2 0.9 
40-44 0.5 1.4 0.8 1.2 
45-49 0.5 1.8 1.4 1.3 
50-54 0.8 2.7 3.4 2.1 
55-59 0.9 4.0 5.9 1.8 
60-64 1.0 5.6 8.7 2.8 
65-69 1.1 8.5 12.8 4.4 
70-74 1.5 11.7 18.5 5.9 
75-79 1.9 14.8 22.0 8.5 
80-84 2.5 18.1 27.3 10.8 
85+ 2.1 15.7 34.5 12.7 
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3. MATERIALS AND METHODS 
Meta-analysis 
Study Identification 
Studies were identified by a comprehensive literature search, review of references, 
government publications, and recommendations from researchers active in the field. The 
criteria used for inclusion were: 
1. The study must be a cohort study examining leukemia in proximity of a nuclear 
site. A study must differentiate between leukemia and lymphoma. 
2. The study must include at least two of the following three variables: observed, 
expected, or endpoint (SMRlSIR) for individual nuclear sites, as opposed to a 
summarization that includes multiple sites. 
3. If a site has zero observed cases or deaths, it will be considered 0.01 for 
calculations. Using 0.01 is conservative in that it will never allow the rate to be 
greater than one (expected are only displayed to two decimal places). 
4. The study must have at least one age category less than 26 (if a study includes age 
categories over the age of 26, only ages less than 26 will be used in the meta-
analysis). 
5. The study must indicate geographic zones in which cases or deaths occurred. 
For multiple studies on the same cohort, the most complete study was used that met 
the study characteristics of interest for each analysis (defined below). The primary 
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criterion used to identify the most complete study was the longest time-interval, and the 
secondary criterion was the most recent publication. 
Thirty-seven studies were identified for possible inclusion. Seventeen studies 
covering 146 nuclear sites in nine countries or former countries (East Gennany) met the 
criteria for at least one analysis. 
Statistical Methods 
Since one of the inclusion criteria is that an endpoint had to be reported for 
individual nuclear sites, each site was considered as an individual study in the meta-
analysis. After the appropriate subset of sites had been identified for each analysis, three 
separate models were used to calculate a meta-SMR and meta-SIR: an overall unadjusted 
(unweighted) model, a fixed effects model, and a random effects model. 
The unadjusted (unweighted) model is the total observed cases or deaths divided 
by the total expected cases or deaths, 
T 
where: 
T = effect size of pooled data (meta-SMR or meta-SIR) 
OJ = observed cases or deaths in the i th study 
Ei = expected cases or deaths in the ith study. 
An alternative model to adjust for sample size is a fixed effects model using the 




T = L...Ji=1 1 1 
l:k ' w· i=1 I 
T = effect size of pooled data (meta-SMR or meta-SIR) 
T; = observed effect size in the lh study 
Wi = weight in the i th study. 
The weight commonly used to minimize the variance ofT is: 
where Vi = variance in the i th study (131-132). 
The meta-analysis combines nuclear sites that perfonn different functions and are 
located in a multitude of environmental settings (with respect to topography, wind, etc.). 
It is unlikely that all studies estimate the same underlying effect size, a fixed effects 
model assumption. One way to account for variation in effect size is to use a random 
effects model. The random effects model is (131,133): 
T. == (). + e., 
I E I 
where: 
Ti = estimate of effect size in the lh study 
8i = true effect size in the lh study 
ej = error with which Ti estimates 8i , and 
var(T; ) == T ~ + Vi , 
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where: 
r~ = between study variance 
Vi = within study variance in the i th study. 
The random effects model is weighted by the inverse of the sum of the between study 
variance and variance in the lh study. 
Forest plots were used to show each site's SMR or SIR and corresponding 95% 
confidence intervals on a logarithmic scale. Ninety-five percent confidence intervals 
were calculated by the method of exact Poisson confidence intervals for standardized 
mortality ratios (134). The forest plot contains several sites and visually represents the 
variability between estimates (131). 
Heterogeneity was analyzed with a Chi-Square Test for Homogeneity (135) and 
graphically, with radial plots, which plot the z-statistic for each study against the 
reciprocal of its standard error (136): 
z = log(SMR i) -log(SMRT ) 
standard error ' 
1 
and standard error = r;;:::;-:\ 
...;(0;) 
where: 
SMRi = may be either SMR or SIR for the ith study 
SMRT = may be either meta-SMR or meta-SIR 
Oi = observed cases or deaths in the ith study. 
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The radial plot also includes an unweighted regression line constrained through 
the origin and corresponding 95% confidence regions. Studies located outside the 950/0 
confidence regions contribute greatly to the heterogeneity (131). 
Publication bias was analyzed with funnel plots, which plot the log of the 
treatment effect from individual studies and the inverse of their standard error (131). 
Publication bias results from a generally accepted belief that studies with significant 
results are more likely to be published than studies with non-significant results. If this is 
true for studies of childhood leukemia in proximity of nuclear sites, the funnel plot will 
be skewed. 
Analysis 
If childhood leukemia from radiation exposure is more likely in young children 
(i.e. 0-9 age group), an analysis of the 0-25 age group may not allow the excess risk to be 
identified. Similarly, if the popUlation living within 10 km of the nuclear site is at a 
much higher risk than the population residing 10-25 km from the site, a study including 
all children residing within a 25 km radius of the nuclear site may again miss a small or 
even moderate excess risk to the 0-10 km population. Since the numerous studies 
examined several different age groups, geographic zones, and endpoint, it was not 
possible to calculate an overall meta-SIR or meta-SMR. Therefore, we developed 
multiple subsets of interest as defined in Table 3.1. 
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Table 3.1 - Stratification of Analysis 
Analysis Age Groupa Geographic Zonea Endpoint 
1 0-9 All SIR 
2 0-9 All SMR 
3 0-9 < 16 kmb SIR 
4 0-9 < 16 kmb SMR 
5 0-25 All SIR 
6 0-25 All SMR 
7 0-25 < 16 kmb SIR 
8 0-25 < 16 kmb SMR 
a. Contains all subsets within the defined range. If more than one study exists for a cohort, the study with 
the largest range within the defined range is used. For example, 0-9 age group may include a study that 
contains only 0-4 age group. 
h. Rounded to the nearest kilometer. For example, 10 miles converts to 16.09 km; therefore it is 
considered 16 Ian. 
Spatial and Temporal Analysis Near Pickering Nuclear Generator 
Temporal Analysis 
The traditional method used to analyze childhood leukemia around nuclear 
facilities is to calculate SIRs for blocks of time since the facility began operation, for 
example, the first 10 years after initial operation and then 11 years to present, or simply, 
before and after the facility began operation. A limitation with the method is that 
choosing time periods is arbitrary and may lead to bias. An alternative method to avoid 
the bias of arbitrary time frames is to use smoothed moving SIRs where researchers select 
a time width (ex. 5 or 10 year width) and calculate an SIR. Next, move the window by a 
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certain increment (ex. 3 years at a time) and again calculate the SIR. Breslow and Day 
suggest the following equation: 
/\ 
where, (} (t) is the SIR estimate at time t, K(x) = smooth, positive kernel function, b = 
bandwidth that determines the degree of smoothness in the estimate, y = number of years 
for which a rate is calculated, di = the number of cases at time ti, and Rt is the total 
standard risk at time ti(137). Rothman suggests using the following kernel: 
K(x)==1-x 2 , when Ixl < 1 
= 0 otherwise. 
Note, using this weight, observations close to t are given the most weight, and 
observations at the end of the bandwidth (ti close to b) are given less weight (138). 
The standard error is 
One could fonn a 100(1-0,)% confidence interval using 
/\ 
B(t) + Z a / 2SE O(t) , 
where Za/2 = upper 1 - ai2 probability from a standard normal distribution. 
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Alternatively, we can use the log scale to better approximate a normal error 
distribution and get more accurate confidence intervals. The confidence intervals on the 
log-scale are given by 
logBCt) + Za/2 * {SECBCt))}/ BCt). 
Transfonning back to the SMR scale, the confidence intervals for 8(t) are 
Smoothed SIRs for 0-4 and 0-14 age groups were calculated and displayed 
graphically for the Pickering Nuclear Generator (PNG) area (within a 12.5 km radius) 
and three control areas. 
Spatial Analysis 
If one is testing whether there is increased risk due to a putative source (i.e. PNG), 
it· makes sense to take the spatial relationship between the cases and the source into 
account (by giving greater weight to cases closer to the source). Focused cluster statistics 
have been designed for this reason. The Score Test of Lawson and Waller will be used in 
our study, as the test is more robust than other focused cluster tests. Generally, the Score 
Test has better power to detect increased risk in a variety of situations including smaller 
sample size, and a gradual decrease in risk with increased distance to the putative source. 
When the cases are clustered into only a few cells, commonly referred to as a 'Hot Spot', 
the Score test performs equal to similar tests (139). 
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In order to perform a focused cluster test, zones must be created around the 
source. The zones are aggregations of census regions. Any census region that has its 
centroid in a given zone can contribute only to that zone. The test statistic is: 
I 
U == Lg;(O; - E i ) 
;=1 
where gi is the exposure to the focus for an individual residing in region i. It has been 
shown, that the inverse of the distance (from the centroid of the region) may be used as a 
surrogate for exposure (140-141). 
The expectation of U is zero under the null hypothesis and the varIance IS 
approximated by the Fisher infonnation: 
I 
Var(U) -- Lg~ Ei , 
i=1 
Uhas an asymptotic standard normal distribution (139). 
Exposure zones were created based solely on distance from the source. Five 
zones were used that were 2.5 km wide with the furthest zone 12.5 km from PNG. 
Exposure zones were also created based on prevailing wind direction at PNG (142). 
Subject Selection 
Data was obtained from Cancer Care Ontario. Criteria for inclusion into at least 
one of the analyses conducted included subjects less than 15 years of age that were 
diagnosed with leukemia (ICD-9, 204-208) between the years· of 1971 and 2000. 
Although childhood leukemia incidence data exists from 1964, Cancer Care 
Ontario was not confident in the completeness and accuracy of the data prior to 1971. 
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Geographic Area Selection 
For the smoothed SIR analysis, the exposed population was comprised of census 
subdivisions that had their centroid within 12.5 km of PNG. The census subdivisions of 
Pickering (in which PNG is located) and Ajax met the criteria and were considered the 
primary exposed population. 
Three control areas consisted of census subdivisions that are similar to 
Pickering/Ajax except for exposure to a nuclear facility. Using 1996 data, 
Pickering/Ajax and the control areas were matched on population density and geographic 
size. All census subdivisions in Ontario, without a nuclear facility, were examined 
individually for possible inclusion into the study. If a census subdivision met the criteria 
for population density but was too small in area, the next most densely populated 
adjoining census subdivision was combined with the selected census subdivision until the 
combined area met the criteria for density and area. The adjoining census subdivision 
must reside in the same census division as the selected census subdivision. The three 
control areas are as follows: Vaughan, Stoney CreekiGrimsby, and Niagara 
FaIlslWellandiThorold. Census Division population counts were also collected for the 
census divisions that contained the selected census subdivisions (Table 3.2). Census 
division and census subdivision population counts are collected every five years; 
therefore, linear interpolation was used to estimate counts for non-reported years. 
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For the spatial analyses, enumeration areas were used. Enumeration areas are the 
smallest geographical area for which census data are reported in Canada. Enumeration 
areas have a maximum of 440 dwellings in urban areas and a minimum of 125 dwellings 
in rural areas. Since enumeration area data was not collected until 1986, the analyses 
were performed on data from 1986-2000. Similar to census subdivisions, enumeration 
areas population counts are collected every five years and linear interpolation was used to 
estimate population counts for non-reported years. 
Software 
All statistical analyses were conducted with SAS 8.2. All mapping, including 




Table 4.1 lists the studies that appeared in at least one analysis. Individual sites 
and values are listed in the Appendix. Table 4.2 shows the number of sites included for 
each analysis. 
Table 4.1: Studies of Childhood Leukemia and Nuclear Facilities used in the Meta-
Analxsis 
Study Country Endpoint 
Age Zone 
GrouEa (km)a 






Goldsmith, 1992 (23) 
Great 
11M 0-9 <16 
Britain 
Ewings et ai., 1989 (19) Great I 0-24 
Districtb, 
Britain <12.5 
Baron, 1984 (1 7) 
Great 
M 0 ... 14 <8 
Britain 
Clarke et ai., 1989 (11) Canada 11M 0-4 Countyb 
Clarke et al., 1991 (12) Canada 11M 0-14 Countyb 
Viel et aI., 1995 (34) France I 0-4, 0-24 <10,<35 
Viel and Richardson, 1990 (32) France M 0-4, 0-24 <35 
Hattchouel et al., 1995 (38) France M 0-25 <16 
Jablon et al., 1990 (143) USA 11M 0-9,0-19 Countyb 
Mohner and Stabenow, 1993 (144) 
East 
I 0-14 <15 
Germany 
Heasman et ai., 1987 (145) Scotland I 0-24 <12.5 
COMARE II, 1988 (8) Scotland I 0-24 <12.5, < 25 
Hole and Gillis, 1986 (146) Scotland I 0-14 
Adj Post 
Codesb 
Kaletsch et al., 1997 (147) West I 0-14 <15 Germany 
Iwasaki et al., 1995 (46) Japan M 0-14 Districtb 
Lopez-Abente et ai., 1999 (49) Spain M 0-24 <15, <30 
a. Categories used in at least 'one analysis. 
b. Considered greater than 16 km. 
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Table 4.2 - Number of Sites by Analysis 
Analysis Age Group Geographic Zone Endpoint Number of sites 
1 0-9 All SIR 22 
2 0-9 All SMR 76 
3 0-9 <16km SIR 13 
4 0-9 <16km SMR 14 
5 0-25 All SIR 50 
6 0-25 All SMR 115 
7 0-25 <16km SIR 41 
8 0-25 <16km SMR 37 
A total of one hundred forty-six sites were used in at least one analysis 
(Burghfield was included in Aldennaston data due to the close proximity of the sites). 
Seventeen studies reported 70 SIRs and 193 SMRs that met the analysis criteria for the 
various sites. Five sites in the USA were excluded due to zero observed deaths and 
expected could not be calculated because only observed and SMR were reported. When 
all geographic zones were used, SMRs were reported at least twice as often as SIRs. 
However, when geographic zones were restricted to < 16 km, SIRs were reported more 
often than SMRs. The great disparity between reporting SIRs and SMRs can be 
attributed to the sites in the USA. Jablon reported 116 SMRs for USA sites, as compared 
to 8 SIRs, that met the criteria (143). The USA study was conducted at the county level 
and the sites are assigned to 'All' geographic region, which also accounts for the 
disparity in number of sites between 'All' and '< 16 km' geographic regions. 
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Analysis 1 
Analysis 1 was restricted to the following conditions: 
• SIR 
• 0 - 9 age group 
• All zones 
Twenty-two sites from Great Britain, Canada, France, and the United States met the 
criteria. Cochran Chi-Square Test for Homogeneity produced a p-value=0.794, 
suggesting that the effect sizes are homogenous. This is further confinned by studying 
the radial plot in Figure 4.1.1. All studies are scattered homoscedastically within two 
standard deviations of the line, whose gradient represents the meta-rate from a fixed 
effects model. The radial plot also can be used to indicate the size of the study. The 
smaller the study, the larger the standard error and consequently, the closer the study will 
be to the y-axis (131). In this case, studies 006, 169, and 353 are far from the y-axis and 
contribute greatly to the meta-rate. Meta-rates are presented in Table 4.3 for all three 
models described in the methods section. Meta-rates are significantly greater than one at 
the alpha=0.05 level of significance. 
Table 4.3 - Meta-SIR, Age Group = 0-9, Geographic Zone = 'All' 
Unadjusted Fixed Effects Random Effects 
Rate 950/0 CI Rate 95% CI Rate 95% CI 
1.21 (1.10,1.33) 1.25 (1.13,1.38) 1.24 (1.12,1.38) 
The Forest Plot (Figure 4.1.2) indicates that the site-specific rates were 
consistently greater than one. Forest Plots contain the site-specific rates and the overall 
meta-rate and their corresponding 95% confidence intervals. Forest Plots can be 
misleading in that the smaller the horizontal bar representing the confidence range, the 
larger the study. Therefore, the site with the smallest bar contributes greatly to the 
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pooled rate and the site with the largest bar contributes the least. In this analysis, site 006 
is the largest study ( smallest bar) and site 018 is the smallest study (largest bar). Looking 
at the forest plot, it is difficult to rule out heterogeneity. 
An important bias to consider when conducting a meta-analysis is publication 
bias. It is often the case that statistically significant results are more likely to be 
published than nonsignificant results. Publication bias is unlikely with regard to 
childhood leukemia and nuclear sites as many of the nuclear sites in the world have had a 
study conducted and published in either a scientific journal or government document. 
However, to be prudent publication bias was checked with the aid of a funnel plot (Figure 
4.1.3). A "funnel" shaped scattering of the studies with approximately equal tails 
indicates that publication bias is not present. There does not appear to be publication 
bias. 
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Figure 4.1.2 - Forest Plot for Random-Effects Meta-SIR, Age Group = 0-9, 
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Analysis 2 was restricted to the following conditions: 
• SMR 
• 0 - 9 age group 
• All zones 
Seventy-six sites from Great Britain, Canada, France, and the United States met the 
criteria. Cochran Chi-Square Test for Homogeneity produced a p-value=0.302, 
suggesting that the effect sizes are homogenous. However, the radial plot in Figure 4.2.1 
indicates sites 203 and 233 may be contributing to heterogeneity. Since sites 135, 173, 
and 211 are located far from the y-axis, they may be contributing greatly to the meta-rate. 
Meta-rates are presented in Table 4.4.1 for all three models described in the methods 
section. Meta-rates are significantly greater than one for the fixed effects and random 
effects model. The unadjusted model has a lower confidence band below one. 
Table 4.4.1- Meta-SMR, Age Group = 0-9, Geographic Zone = 'All' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95%CI 
1.03 (0.98, 1.08) 1.06 (1.01,1.11) 1.06 (1.01,1.12) 
The analysis was rerun without sites 203 and 233. Although the change in overall 
results was slight, the fixed effects model was no longer statistically significant (Table 
4.4.2). 
52 
Table 4.4.2 - Meta-SMR, Age Group = 0-9, Geographic Zone = 'All', Excluding 
Sites that may be Contributing to Heterogeneity 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 950/0 CI 
1.03 (0.98, 1.08) 1.05 (1.00,1.11) 1.05 (1.01,1.11) 
The Forest Plot (Figure 4.2.2) indicates that the site-specific rates generally 
remained near one, although many of the larger studies had rates greater than one. The 
funnel plot (Figure 4.2.3) does not indicate evidence of publication bias. 
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Analysis 3 was restricted to the following conditions: 
• SIR 
• 0 - 9 age group 
• < 16 km geographic zone 
Twelve sites from Great Britain and one site from France met the criteria. Cochran 
Chi-Square Test for Homogeneity produced a p-value=O.314, suggesting that the effect 
sizes are homogenous. This is further confirmed by studying the radial plot in Figure 
4.3.1 where all studies are scattered homoscedastically within two standard deviations of 
the line. Since sites 003 and 006 are located far from the y-axis, they may be 
contributing greatly to the meta-rate. Meta-rates are presented in Table 4.5 for all three 
models described in the methods section. Meta-rates are significantly greater than one 
for all models. 
Table 4.5 - Meta-SIR, Age Group = 0-9, Geographic Zone = '< 16 km' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95% CI 
1.18 (1 ~04, 1.35) 1.23 (1.07, 1.40) 1.22 (1.05,1.41) 
The Forest Plot (Figure 4.3.2) indicates that the site~specific rates were generally 
greater than one. Although there are only thirteen sites, the funnel plot (Figure 4.3.3) 
does not indicate evidence of publication bias. 
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Figure 4.3.2 - Forest Plot for Random-Effects Meta-SIR, Age Group = 0-9, 
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Analysis 4 was restricted to the following conditions: 
• SMR 
• 0 - 9 age group 
• < 16 km geographic zone 
Fourteen sites from Great Britain met the criteria. Cochran Chi-Square Test for 
Homogeneity produced a p-value=O.275, suggesting that the effect sizes are homogenous. 
This is further confirmed by studying the radial plot in Figure 4.4.1 where all studies are 
scattered homoscedastically within two standard deviations of the line. Since sites 004, 
005,015 and 032 are located far from the y-axis, they may be contributing greatly to the 
meta-rate. Meta-rates are presented in Table 4.6 for all three models described in the 
methods section. Meta-rates are significantly greater than one for the fixed effects and 
random effects model. The unadjusted model has a lower confidence band below one. 
Table 4.6 - Meta-SMR, Age Group = 0-9, Geographic Zone = '< 16 km' 
Unadjusted Fixed Effects Random Effects 
Rate 95%CI Rate 95% CI Rate 95%CI 
1.17 (0.99, 1.38) 1.23 (1.04, 1.46) 1.24 (1.03, 1.50) 
The Forest Plot (Figure 4.4.2) indicates that the site-specific rates were generally 
greater than one. Although there are only fourteen sites, the funnel plot (Figure 4.4.3) 
appears to be skewed to the left indicating there may be publication bias. However, this 
could be an artifact of too few studies appearing in the funnel plot. 
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Figure 4.4.2 - Forest Plot for Random-Effects Meta-SMR, Age Group = 0-9, 
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Analysis 5 was restricted to the following conditions: 
• SIR 
• 0 - 25 age group 
• All geographic zones 
Fifty sites from Great Britain, Canada, France, United States, Scotland, West 
Gennany, and East Germany met the criteria. Cochran Chi-Square Test for Homogeneity 
produced a p-value=O.598, suggesting that the effect sizes are homogenous. However, 
the radial plot in Figure 4.5.1 indicates that site 006 may be contributing to heterogeneity. 
Since sites 001, 024, 051 and 242 are located far from the y-axis, they may be 
contributing greatly to the meta-rate. Meta-rates are presented in Table 4.7.1 for all three 
models described in the methods section. Meta-rates are significantly greater than one 
for all models. 
Table 4.7.1 - Meta-SIR, Age Group = 0-25, Geographic Zone = 'All' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95%CI 
1.1 0 ( 1.04, 1 .16) 1.12 (1.06,1.18) 1.12 (1.06, 1.18) 
The analysis was rerun without sites 006. There was no change in statistical 
significance for the three models (Table 4.7.2). 
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Table 4.7.2 - Meta-SIR, Age Group = 0-25, Geographic Zone = 'All', Excluding 
Sites that may be Contributing to Heterogeneity 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95%CI 
1.08 (1.02,1.15) 1.10 (1.04,1.17) 1.10 ( 1.04, 1.1 7) 
The Forest Plot (Figure 4.5.2) indicates that the site-specific rates generally 
remained near one, although many of the larger studies had rates greater than one. The 
funnel plot (Figure 4.5.3) does not indicate evidence of publication bias. 
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Fi!!ure 4.5.3 - Funnel Plot for Meta-SIR, A 
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Analysis 6 was restricted to the following conditions: 
• SMR 
• 0 - 25 age group 
• All geographic zones 
One hundred and fifteen sites from Great Britain, Canada, France, Japan, Spain, and 
United States met the criteria. Cochran Chi-Square Test for Homogeneity produced a p-
value=0.183, suggesting that the effect sizes are homogenous. However, the radial plot 
in Figure 4.6.1 indicates that sites 080, 124, 202, and 232 may be contributing to 
heterogeneity. Since sites 134, 128, 172 and 210 are located far from the y-axis, they 
may be contributing greatly to the meta-rate. Meta-rates are presented in Table 4.8.1 for 
all three models described in the methods section. Meta-rates are greater than one for all 
models but none are significant. 
Table 4.8.1- Meta-SMR, Age Group = 0-25, Geographic Zone = 'All' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95% CI 
1.00 (0.96, 1.03) 1.02 (0.98, 1.06) 1.02 (0.98, 1.06) 
The analysis was rerun without the sites that may be contributing to 
heterogeneity. There was no change in rates or confidence intervals for the three models 
(Table 4.8.2). 
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Table 4.8.2 - Meta-SMR, Age Group = 0-25, Geographic Zone = 'All', Excluding 
Sites that may be Contributing to Heterogeneity 
Unadjusted Fixed Effects Random Effects 
----------------------~~~~~-~-------------------------------------------------------------~~~~~-~-------------------
Rate 950/0 CI Rate 950/0 CI Rate 95% CI 
1.00 (0.96, 1.04) 1.02 (0.98, 1.06) 1.02 (0.98, 1.06) 
The Forest Plot (Figure 4.6.2) indicates that the site-specific rates scattered 
around one. The funnel plot (Figure 4.6.3) does not indicate evidence of publication bias. 
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Fi!!ure 4.6.3 - Funnel Plot for Meta-SMR, A 
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Analysis 7 was restricted to the following conditions: 
• SIR 
• 0 - 25 age group 
• < 16 km geographic zone 
Forty-one sites from Great Britain, France, Scotland, West Germany, and East 
Germany met the criteria. Cochran Chi-Square Test for Homogeneity produced a p-
value=O.243, suggesting that the effect sizes are homogenous. However, the radial plot 
in Figure 4.7.1 indicates that sites 006 and 085 may be contributing to heterogeneity. 
Since sites 001, 006, and 242 are located far from the y-axis, they may be contributing 
greatly to the meta-rate. Meta-rates are presented in Table 4.9.1 for all three models 
described in the methods section. Meta-rates are significantly greater than one for all 
models. 
Table 4.9.1 - Meta-SIR, Age Group = 0-25, Geographic Zone == '< 16 km' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95% CI 
1.08 (1.01,1.15) 1.11 (1.03,1.18) 1.10 (1.03,1.19) 
The analysis was rerun without the sites that may be contributing to heterogeneity. 
Meta-rates remain greater than one but were no longer significant (Table 4.9.2). 
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Table 4.9.2 - Meta-SIR, Age Group = 0-25, Geographic Zone = '< 16 km', 
Excluding Sites that may be Contributing to Heterogeneity 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 950/0 CI 
1.05 (0.98,1.13) 1.02 (0.98, 1.06) 1.07 (1.00,1.15) 
The Forest Plot (Figure 4.7.2) indicates that the site-specific rates scattered 
around one with many of the larger studies greater than one. The funnel plot (Figure 
4.7.3) does not indicate evidence of publication bias. 
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Figure 4.7.2 - Forest Plot for Random-Effects Meta-SIR, Age Group = 0-25, 
Geo ra hie Zone = '< 16 km' 
Forest Plot 
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Analysis 8 was restricted to the following conditions: 
• SMR 
• 0 - 25 age group 
• < 16 km geographic zone 
Thirty-seven sites from Great Britain, France, Japan, and Spain met the criteria. 
Cochran Chi-Square Test for Homogeneity produced a p-value=0.440, suggesting that the 
effect sizes are homogenous. However, the radial plot in Figure 4.8.1 indicates that site 
002 may be contributing to heterogeneity. Since site 002 is located far from the y-axis, 
the site with possible heterogeneity may be contributing greatly to the meta-rate. Meta-
rates are presented in Table 4.10.1 for all three models described in the methods section. 
Meta-rates are greater than one for all models, but none are significant. 
Table 4.10.1- Meta-SMR, Age Group = 0-25, Geographic Zone = '< 16 km' 
Unadjusted Fixed Effects Random Effects 
Rate 95% CI Rate 95% CI Rate 95%CI 
1.01 (0.90, 1.14) 1.09 (0.97, 1.23) 1.09 (0.97, 1.23) 
The analysis was rerun without the sites that may be contributing to heterogeneity. 
Meta-rates increased and fixed effects and random effects models were now statistically 
significant (Table 4.10.2). 
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Table 4.10.2 - Meta-SMR, Age Group = 0-25, Geographic Zone = '< 16 km', 
Excluding Sites that may be Contributing to Heterogeneity 
Unadjusted Fixed Effects Random Effects 
.... ~ .. ~---------------------------------------------~--------------------------------------------------------------
Rate 95%CI Rate 95%CI Rate 95%CI 
1.08 (0.94, 1.23) 1.18 (1.03,1.34) 1.18 (1.03,1.34) 
The Forest Plot (Figure 4.8.2) indicates that the site-specific rates scattered 
around one. The funnel plot (Figure 4.8.3) does not indicate evidence of publication bias. 
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Figure 4.8.2 - Forest Plot for Random-Effects Meta-SMR, Age Group = 0-25, 
Geo ra hie Zone = '< 16 km' 
Forest Plot 
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When determining whether a study within the "< 16 km" zone captured cases that 
truly lie within 16 kilometers or whether only some part of the census boundary lay 
within 16 kilometers was not generally specified. For that reason, a study met the criteria 
as long as some part of the census boundary was within the zone. For Aldermaston, the 
algorithm led us to use data from a study that has at least one-third of the population 
within 10 miles (16 km) of the site. It is possible that the majority of the population 
resided outside the zone. However, data was also available that had at least two-thirds of 
the population within 8 miles (13 km) of the site. Using observed and expected as an 
indicator of population size, the disparity in population between the above analyses is 
evident (Table 4.11). For example, the 10-mile region expects an eight-fold increase in 
the number of cases, as compared to the 8-mile region. While the SIR for the 8-mile 
region is slightly larger than the 10-mile region, the 10-mile region may have a greater 
influence when calculating the meta-SIR due to the size of the population. 
Table 4.11 - Study Population Comparison for Aldermaston 
ReBion Ase GrouE Obs EXE SIR 
1/3 population 0-9 51 42.15 1.21 
within 10 miles 
0-25 82 70.09 1.17 
-------~---~--------------------------------------------------------~--~-----~~---------
2/3 population 0-9 8 5.49 1.46 
within 8 miles 
0-25 14 8.81 1.59 
85 
Therefore, SIR analyses for both age groups in geographic zone = '< 16 lan' were 
reanalyzed by substituting the 8-mile for the 10-mile region (Table 4.12). There was no 
change is significance for the 0-9 age group. In the 0-25 age group, the lower confidence 
interval is below one changing all models from significant to nonsignificant. 
Table 4.12 -1/3 pop within 10 miles of Aldermaston to 2/3 pop within 8 miles 
_______ Y~~cJj~~!~~ _ ~ __________ ~!~~~_~ffe_~!~ _____________ R~~~_~~_ ~ff~~!~ __ . 
Age Geographic . . 
Group Zone Rate 95% CI Rate 95% CI Rate 95% CI 
0-9 < 16 km 1.19 (1.02, 1.38) 1.24 (1.07, 1.44) 1.23 ( 1.04, 1.44) 
0-25 < 16 km 1.04 (0.97, 1.12) 1.07 (0.99,1.15) 1.07 (0.99, 1.15) 
Spatial and Temporal Analysis Near Pickering Nuclear Generator 
Temporal Analysis 
Overall SIR and smoothed moving SIR graphs were produced for 0-4 and 0-14 
age groups at the census division level. The analysis was also performed at the census 
subdivision level for 0-14 age group. However, the smaller population and fewer cases 
did not allow for smoothed moving SIRs for 0-4 age group to be studied at the census 
subdivision level. The smoothing consisted of five-year intervals, moved in two, three, 
four, and five-year increments. 
The overall SIR for the four census subdivision areas, ages 0-14 are shown in 
Table 4.13 .. Pickering/Ajax, in which Pickering Nuclear Generator (PNG) resides, had no 
increase in the overall SIR. Of the control areas, Stoney Creek/Grimsby had an SIR 
86 
below one, Vaughan had a statistically non-significant SIR greater than one, and Niagara 
FallslWellandlThorold had a statistically significant rate, SIR 2.68. 
Table 4.13 - Overall SIR by Census Subdivision 1971-2000 - Age 0-14 
Census Subdivsion Group Obs Exp SIR 95%CI 
Pickering/Ajax 37 37.48 0.99 (0.70, 1.36) 
Vaughan 29 26.30 1.10 (0.74,1.58) 
Stoney Creek/Grimsby 9 19.15 0.47 (0.21, 0.89) 
Niagara F all slW ellandiThorold 37 13.81 2.68 (1.89,3.69) 
Table 4.14 shows the overall SIR for the four census division areas, ages 0-14. 
Also included is Essex, a border census division similar to Niagara in that they are near 
populated cities in the u.S. Essex was added a posteriori for comparison to Niagara 
because the census divisions share many of the same characteristics. The census division 
of Durham contains PNG. Although Durham, York, and Niagara have SIRs greater than 
one, none are statistically significant. Hamilton-Wentworth and Essex have SIRs below 
one. 
Table 4.14 - Overall SIR by Census Division 1971-2000 - Age 0-14 
Census Divsion Obs Exp SIR 95%CI 
Durham 141 128.82 1.09 (0.86, 1.40) 
York 156 136.34 1.14 (0.90, 1.45) 
Hamilton-Wentworth 119 133.18 0.89 (0.69, 1.15) 
Niagara 123 117.00 1.05 (0.81,1.37) 
Essex 98 106.62 0.92 (0.69, 1.22) 
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The overall SIR for the four census division areas, age group 0-4 is shown in 
Table 4.15. All SIRs are near one and none are statistically significant. 
Table 4.15 - Overall SIR by Census Division 1971-2000 - Age 0-4 
Census Division Obs Exp SIR 95% CI 
Durham 78 70.78 1.10 (0.87, 1.38) 
York 77 73.24 1.05 (0.83,1.31) 
Hamilton-Wentworth 70 71.97 0.97 (0.76, 1.23) 
Niagara 68 61.33 1.11 (0.86, 1.41) 
Essex 60 56.93 1.05 (0.80, 1.36) 
Smoothed Moving SIR for Census Subdivisions Pickering and Ajax: 0-14 
Age Group 
Pickering and Ajax are the census subdivisions that are most likely at the highest 
risk of radiation exposure from PNG. The overall SIR for childhood leukemia from 
1971-2000 was 0.99 (95% CI= 0.70, 1.36). Smoothed moving windows with five year 
intervals were created and moved in two, three, four, and five-year increments (Figures 
4.9.1-4, respectively). Moving the window in two-year increments offer the least amount 
of smoothing and five-year increments generates the greatest amount of smoothing. All 
four increments indicate SIRs below one with upper confidence bands above one until 
approximately 1980; and from 1980-2000 the SIR consistently remained near one with 
nonsignificant confidence bands. 
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Figure 4.9.1 - Census Subdivision Pickering and Ajax, Age 0-14 
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Figure 4.9.3 - Census Subdivision Pickering and Ajax, Age 0-14 
4 Year Increments 
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Smoothed Moving SIR for Census Subdivision Vaughan: 0-14 Age Group 
The overall SIR for childhood leukemia from 1971~2000 was 1.10 (95% CI= 
0.74, 1.58). The smoothed moving windows are shown in Figures 4.10.1-4. Vaughan 
experienced excess cases of childhood leukemia in the 1970's and early 1980's, 
achieving significance around 1980. Throughout the 1980s and 1990s, the two-year and 
three-year increments show the smoothed SIR oscillating around one. However the four-
year and five-year increments suggest a downward trend during that same time period. 
The early excess cases are most likely what account for the overall SIR being greater than 
one. 
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2 Year Increments 
weighted MoVing Rve V.;)r SIR Averag.$: Vaughan (2 year iner.m ents) 
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4 Year Increments 
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Smoothed Moving SIR for Census Subdivisions Stoney Creek and Grimsby: 
0-14 Age Group 
The overall SIR for childhood leukemia from 1971-2000 was 0.47 (950/0 CI= 
0.21, 0.89). The smoothed moving windows are shown in Figures 4.11.1-4. The 
smoothed SIR remained consistently below one for the entire study period. Although the 
smoothed SIRs failed to achieve significance, the overall SIR was significant. 
94 
Figure 4.11.1 - Census Subdivisions Stoney Creek and Grimsby, Age 0-14 
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Figure 4.11.3 - Census Subdivisions Stoney Creek and Grimsby, Age 0-14 
4 Year Increments 
Weighted MoVing Flw Year SIR A wrages: Stoney Creek and Grim s by (4 year Jn~em ants) 
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Smoothed Moving SIR for Census Subdivisions Niagara Falls, Weiland, and 
Thorold: 0-14 Age Group 
The overall SIR for childhood leukemia from 1971-2000 was 2.68 (95% CI= 
1.89,3.69). The smoothed moving windows are shown in Figures 4.12.1-4. Except for 
one point in the last 1970s, the smoothed SIRs remained consistent and above one, often 
achieving significance. 
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Figure 4.12.1 - Census Subdivisions Niagara Falls, WeIland, and Thorold, 
A e 0-14 2 Year Increments 
Weighted Mo",ng Five Vear SIRA wrages: Nagara Falls. Weiland, and Thorold (2 year incram ants) 
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Figure 4.12.3 - Census Subdivisions Niagara Falls, Weiland, and Thorold, 
A e 0-14 4 Year Increments 
Weighted Mo~ng Five Year SIRAwrages: Nagara Falls. Weiland. and Thorold· 
(4 yen Incrern .nts. 
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Smoothed Moving SIR (or Census Division Durham: 0-14 Age Group 
The census division of Durham contains the census subdivisions of Pickering and 
Ajax, and consequently PNG. The overall SIR for childhood leukemia from 1971-2000 
was 1.09 (95% CI= 0.86, 1.40). The smoothed moving windows are shown in Figures 
4.13.1-4. The smoothed SIRs always remained near one for the study period never 
achieving statistical significance. 
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Fi ore 4.13.1 - Census Division Durham, A e 0-14 2 Year Increments 
Weighted Moving Five Vear SIRAvera.ges: Durham County (2 year increments) 
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F~gure 4.13.3 - Census Division Durham, A2e 0-14 (4 Year Increments) 
Weighted Moving Five Ve .. SIRAverages: Durham County (4 year Increments) 
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Smoothed Moving SIR for Census Division Durham: 0-4 Age Group 
Census divisions have large enough populations to also produce smoothed 
moving SIRs for the 0-4 age group. The overall SIR for childhood leukemia from 1971-
2000 was 1.10 (95% CI= 0.87, 1.38). The smoothed moving windows are shown in 
Figures 4.14.1-4. The smoothed SIRs for the 0-4 age group followed the same pattern as 
the 0-14 age group, consistently remaining near one and never achieving significance. 
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Fi ure 4.14.1- Census Division Durham, A e 0-4 2 Year Increments 
W.lghted MoVing Five Year SIR A wrag.s: Durham County - Ag. O~ 
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Fi ure 4.14.3 - Census Division Durham, A e 0-4 4 Year Increments 
Weighted MoVIng Fa ... Year SIR A \'erages: Durham County - Age 0-4 
(4 year increments) 
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Smoothed Moving SIR for Census Division York: 0-14 Age Group 
The census division of York contains the census subdivision of Vaughan. The 
overall SIR for childhood leukemia from 1971-2000 was 1.14 (95% CI= 0.90, 1.45). The 
smoothed moving windows are shown in Figures 4.15.1-4. The smoothed SIRs follow 
the same pattern as Vaughan with elevated rates in the late 1970s and early 1980s 
sometimes achieving statistical significance. During the remainder of the study period, 
rates consistently stayed near one. 
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Fi ure 4.15.1 - Census Division York, A e 0-14 2 Year Increments 
Weighted Moving Rve Year SIR Averages: York County 12 year Inc rem ents) 
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Fi nre 4.15.3 - Census Division York, A e 0-14 4 Year Increments 
Weighted Moving Ave Year SIR Averages: York county (4 year Increm ents) 
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Smoothed Moving SIR (or Census Division York: 0-4 Age Group 
The overall SIR for childhood leukemia from 1971-2000 was 1.05 (95% CI= 
0.83, 1.31), slightly lower than the SIR of 1.10 experience for the 0-14 age group. The 
smoothed moving windows are shown in Figures 4.16.1-4. The trend is the same as the 
0-14 age group, with elevated rates (sometimes significant) in the late 1970s and early 
1980s and remaining near one for the rest of the study period. 
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Fi ure 4.16.1 - Census Division York, A e 0-4 2 Year Increments 
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Fi ore 4.16.3 - Census Division York, A e 0-4 4 Year Increments 
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Smoothed Moving SIR (or Census Division Hamilton-Wentworth: 0-14 Age 
Group 
The census division of Hamilton-Wentworth contains the census subdivisions of 
Stoney Creek and Grimsby. The overall SIR for childhood leukemia from 1971-2000 
was 0.89 (95% CI= 0.69, 1.15). Although higher than the overall SIR of 0.47 for Stoney 
Creek and Grimsby, the rate is still well below one. The smoothed moving windows are 
shown in Figures 4.17.1-4. The smoothed SIRs generally remained below one. For a 
brief period in the mid 1980s the rates were slightly statistically significantly below one 
for all increments except the 5-year increment. 
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Figure 4.17.1 - Census Division Hamilton-Wentworth, Age 0-14 (2 Year 
Increments 
Weighted Moving Five Year SIR Awrlllges: tQmilton-Wentworth County (2 year increments. 
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Figure 4.17.2 - Census Division Hamilton-Wentworth, Age 0-14 (3 Year 
Increments 
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10 ........... - ........................................................................................................................................................................................................ _ .................................................................. ·················· .. ········ .. ···· .. ············1 
o_,+-----------~--------------~------------~--------------~--~--~~~~ 
1971 1976 1982 1988 1994 2000 
Vear 
113 
Figure 4.17.3 - Census Division Hamilton-Wentworth, Age 0-14 (4 Year 
Increments 
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Smoothed Moving SIR for Census Division Hamilton-Wentworth: 0-4 Age 
Group 
The overall SIR for childhood leukemia from 1971-2000 was 0.97 (95% CI= 
0.76,1.23). Although higher than the overall SIR of 0.89 for the 0-14 age group, the rate 
is still slightly below one. The smoothed moving windows are shown in Figures 4.18.1-
4. The smoothed SIRs remained near one until the mid 1980s when the rates dropped 
well below one. For a brief period in the mid 1990s the smoothed SIRs were greater than 
one. However, statistical significance was never achieved. 
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Figure 4.18.1 - Census Division Hamilton-Wentworth, Age 0-4 (2 Year 
Increments 
Weighted Moving Five Year SIR Averages: Ham ilton·Wentw orth County· Age 0-4 ,2 y.ar increm ents) 
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Smoothed Moving SIR [or Census Division Niagara: 0-14 Age Group 
The census division of Niagara contains the census subdivisions of Niagara Falls, 
WeIland, and Thorold. The overall SIR for childhood leukemia from 1971-2000 was 
1.05 (95% CI:::::: 0.81, 1.37), well below the statistically significant overall SIR of 2.68 
experienced by the census subdivisions. The smoothed moving windows are shown in 
Figures 4.19.1-4. Unlike the census subdivision smoothed SIRs that were above one for 
the entire study period, the census division smoothed SIRs stayed consistently near one. 
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Fig~re 4.19.3 ~ Census Division Niagara, Age 0-14 (4 Year Increments) 
Weighted MoYlng Ave Year SIR Average$: Nagar a county (4 year Increments) 
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Smoothed Moving SIR for Census Division Niagara: 0-4 Age Group 
The overall SIR for childhood leukemia from 1971-2000 was 1.11 (95% CI= 
0.86, 1.41), slightly higher than the overall SIR for the 0-14 age group. The smoothed 
moving windows are shown in Figures 4.20.1-4. The smoothed SIRs remained near one 
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Weighted Moving Five Year SIR Averages: NIagara County -Age 0-4 
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Smoothed Moving SIR for Census Division Essex: 0-14 Age Group 
Essex was added a posteriori for comparison to Niagara because the census 
divisions share many of the same characteristics. In particular, both census divisions are 
similarly populated and near populated cities in the u.s. Although it would have been 
preferable to include census subdivisions within Essex, since it was the census 
subdivisions in Niagara that had elevated rates, it was not possible to do so because of 
multiple changes within the census subdivisions in Essex during the study period. 
Therefore, census division is the smallest geostatistical unit in that area that can be 
considered reliable. The overall SIR for childhood leukemia from 1971-2000 was 0.92 
(95% CI= 0.69, 1.22). The smoothed moving windows are shown in Figures 4.21.1-4. 
The smoothed SIRs remained near one for the first half of the study period and then 
began a downward trend for the rest of the study period. 
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Fi ure 4.21.1 - Census Division Essex, A e 0-14 2 Year Increments 
Weighted Moving Five Year SIR Ave-rages: Essex County (2year Inc rem ents) 
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Fi ure 4.21.3 - Census Division Essex, A e 0-14 4 Year Increments 
Weighted Moving Fiv. Year SIR Averages: Ess.x County (4 year Increm ents) 
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Smoothed Moving SIR for Census Division Essex: 0-4 Age Group 
The overall SIR for childhood leukemia from 1971-2000 was 1.05 (95% CI= 0.80 
1.36), higher than the 0-14 age group. The smoothed moving windows are shown in 
Figures 4.22.1-4. The smoothed SIRs followed the same general trend at the 0-14 age 
group, remaining near one for the first half of the study and below one for the rest of the 
time. 
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Fi ure 4.22.1 - Census Division Essex, A e 0-4 2 Year Increments 
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Fi ure 4.22.3 - Census Division Essex, A e 0-4 4 Year Increments 
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Additional Analysis: Overall SIR for Census Subdivisions Pickering, Ajax, 
Whitby, Oshawa, Scarborough, and Markham: 0-14 Age Group 
The original studies by Clarke that analyzed childhood leukemia near PNG 
included the six census subdivisions of Pickering, Ajax, Whitby, Oshawa, Scarborough, 
and Markham (Figure 4.23) (11-12). Although it would have been preferable to 
reanalyze the original area, it was not possible because Scarborough dissolved in 1999 
becoming part of Greater Toronto. It was possible to calculate an overall rate from 1971-
1998. For the time period 1971-1998, the overall SIR was 0.94 (95% CI = 0.79, 1.13), 
slightly lower than the 1971-2000 overall SIR of 0.99 experienced by only Pickering and 
Ajax. Scarborough and Markham are the two census subdivisions that most likely 
receive the least amount of radiation yet contain the majority of the population. If 
Scarborough and Markham are excluded, the overall SIR from 1971-2000 for Pickering, 
Ajax, Oshawa, and Whitby is 1.13 (95% CI = 0.93, 1.36). The above analysis 
considered with the overall SIR=0.99 for Pickering and Ajax alone (see beginning of 
section), suggests that the excess cases for the study area were found in Oshawa and 
Whitby. 
130 






The unadjusted zones for wind direction are shown in Figure 4.24. The semi-
circles represent the five zones with each zone 2.5 km wide and extending 12.5 km from 
PNG. The remainder of the lines on the figure represents enumeration area boundaries. 
Because enumeration areas consist of between 125-440 dwellings, it is easy to determine 
on the map areas of high population density: geographically smaller enumeration areas 
are more densely populated than larger enumeration areas. For example, one can see that 
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the densely populated areas are near Lake Ontario. The outer three unadjusted zones 
include a large portion of Scarborough, a densely populated section of Toronto, west of 
PNG. The inner two zones include the densest sections of Pickering and Ajax, the areas 
most likely at risk. The zones adjusted for wind direction are shown in Figure 4.25. The 
adjusted zones retain a small section of Scarborough but only in the outer most band, thus 
adding little weight to the overall p-value while maintaining the densest sections of 
Pickering and Ajax in the two inner most zones, which receive the greatest weight. 
Figure 4.24 - Pickering Nuclear Generator (unadjusted for wind). SIR 
for 0-14 a 
SIR (Obs) 
1 1.83 (4) 
2 1.10 (17) 
3 1.30 (11) 
4 0.67 (4) 
132 
Figure 4.25 - Pickering Nuclear Generator (adjusted for wind). SIR for 
0-14 a 
1 
2 0.95 (8) 
3 0.90 (1) 
4 1.33 (13) 
Table 4.16 shows the observed and expected cases of childhood leukemia by 
zones when there is no adjustment for wind. Zones one and five have the highest rates 
for both age groups. One can also see that the largest populations are found in zones two 
and five. Zone two contains the majority of the population of Pickering and Ajax; 
whereas zone five's population is primarily found near the water, Scarborough to the 
west and Whitby to the east, and sparsely populated to the north (Figure 4.24). There 
does not appear to be an obvious trend of decreasing rates with increasing distance. 
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Table 4.16 - Unadjusted Zones of SIR for Childhood Leukemia in Proximity to 
Pickering Nuclear Generator 
Age Group 0-4 Age Group 0-14 
._---------------------------------------------- --------------------------------------------
Zone Observed Expected SIR Observed Expected SIR 
1 3 1.27 2.36 4 2.18 1.83 
2 9 8.89 1.01 17 15.47 1.10 
3 4 4.77 0.84 11 8.47 1.30 
4 0 3.27 4 5.99 0.67 
5 16 9.81 1.63 27 17.13 1.58 
Table 4.17 shows the observed and expected by zones when adjustment for wind. 
The highest rates are found in zones one, four, and five for both age groups. Compared 
to the unadjusted zones, the adjusted zones populations are more evenly distributed, with 
the exception of zone one. Although the highest rates are found in the first zone, there 
does not appear to be a trend with distance. 
Table 4.17 -Wind adjusted Zones of SIR for Childhood Leukemia in Proximity to 
Pickering Nuclear Generator 
Age Group 0-4 Age Group 0-14 
.-~---~----------------------------------------- --------------------------------------------
Zone Observed Expected SIR Observed Expected SIR 
1 2 0.36 5.54 2 0.62 3.25 
2 1 5.01 0.20 8 8.42 0.95 
3 4 4.64 0.86 7 7.76 0.90 
4 8 5.36 1.49 13 9.77 1.33 
5 5 3.44 1.45 13 6.50 2.00 
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Two weights were used to calculate the Score Test of Lawson and Waller. The 
first weight was the inverse of the distance, where distance is defined as the distance from 
the centroid of the zone to PNG. The second weight was the inverse of the square of the 
distance. Neither the 0-4 or 0-14 age groups had significant p-values for either zone type 
or either weight (Table 4.18). However, p-values were greater for adjusted zones 
compared to unadjusted zones when the weight was 1/distance. Adjusting for wind and 
using 1 Idistance2 decreased the p-value compared to the unadjusted modeL Further, 
after adjusting for wind, p-values were smaller for 1/distance2 when compared to 
I/distance. 
Table 4.18 - Score Test of Lawson and Waller P-values by Zone Type and Age 
Group 
Weight and Exposure Zone 
weight = 1 / distance 
Unadjusted for wind direction 
Adjusted for wind direction 
weight = 1 / distance2 
Unadjusted for wind direction 
Adjusted for wind direction 








We attempted to assemble the most complete list of professional journals and 
government publications, in English and other languages, from around the world that 
studied childhood leukemia in the vicinity of nuclear facilities. Observed and expected 
numbers were available for one hundred and forty-six nuclear sites in nine countries or 
former countries. The number of sites allowed for multiple analyses stratified by area 
and age. We were able to develop unadjusted models, fixed effects models and random 
effects models. Meta-SMRs and meta-SIRs were all at least one. 
Tables 5.1 and 5.2 summarize the meta-rates by strata. Within geographic zones 
and for meta-SMRs and meta-SIRs, the 0-9 age group experienced higher standardized 
rates than the 0-25 age group, suggesting that the 0-9 age group accounted for the 
majority of the excess cases and deaths. No pattern was found when comparing 
geographic zones within age groups. When comparing geographic zones within age 
groups, meta-SMRs were consistently higher for the "< 16 km" zone compared to the 
"All" zone. F or meta-SIRs, rates were essentially the same with a slight increase for the 
"All" zone compared to the "< 16 km" zone. 
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Table 5.1 - Meta-SMR for Childhood Leukemia hI Strata 
Age Geographic Fixed Effects Random Effects 
--------~-~-----------------------------------------------------------------------
Group Zone Rate 95%CI Rate 95%CI 
0-9 All 1.06 (1.01,1.11) 1.06 (1.01,1.12) 
0-9 <16km 1.23 (1.04,1.46) 1.24 (1.03, 1.50) 
0-25 All 1.02 (0.98, 1.06) 1.02 (0.98, 1.06) 
0-25 <16km 1.09 (0.97, 1.23) 1.09 (0.97,1.23) 
Table 5.2 - Meta-SIR for Childhood Leukemia bI Strata 
Age Geographic Fixed Effects Random Effects 
----------------------------------------------------------------~---~--------------
Group Zone Rate 95%CI Rate 95%CI 
0-9 All 1.25 (1.13,1.38) 1.24 (1.12, 1.38) 
0-9 < 16km 1.23 (1.07, 1.40) 1.22 (1.05,1.41) 
0-25 All 1.12 (1.06, 1.18) 1.12 (1.06,1.18) 
0-25 <16km 1.11 (1.03,1.18) 1.10 (1.03,1.19) 
It is highly unlikely studies for different nuclear sites estimate the same 
underlying effect size. This is so because there are multiple types of nuclear facilities, 
including nuclear generators operating at differing capacities, nuclear reprocessing sites, 
nuclear weapons sites, and uranium mining sites. Therefore, even in the absence of 
evidence of heterogeneity between studies in a given strata, the use of a random effects 
model is more appropriate. In this meta-analysis, the meta-rates for the fixed effects and 
random effects models agree so closely, that the choice of model is not critical. 
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The most common childhood cancer is leukemia. The incidence rates for 
childhood leukemia are highest in the 0-4 age group and decrease with each increasing 
five-year age group until 25 years of age. Table 5.3 contains 1990 incidence rates per 
100,000 for the United Kingdom, Canada, Osaka, Japan (Japan's largest cancer registry) 
(158) and, SEER region of the United States (comprising 14% of United States 
population) (159). Using these incidence rates and the meta-SIRs based on all zones to 
determine excess cases near nuclear facilities, we would expect between one and two 
cases associated with living near a nuclear facility in the 0-9 age group and under one 
case if the entire 0-24 age group is considered, again suggesting the excess cases are in 
the 0-9 age group. 
Table 5.3 -1990 Incidence Rates and Expected Excess Cases per 100,000 for 







_______ Q:-~ {~~~~-_~J~~_I_·_~~2 ________________ Q~~~_ {!!1:~!~:-~!g ~ J_·A~} ________ . 
Rate Excess Cases Rate Excess Cases 
5.13 1.23 3.29 0.39 
5.73 1.38 3.59 0.43 
5.52 1.32 3.60 0.43 
4.35 1.04 3.15 0.38 
Although many of the world's nuclear sites are represented in the meta-analysis, 
the inclusion rules did not allow certain sites to be used in calculating meta-rates. For 
example, four nuclear sites in Sweden were not included because a spatial analysis was 
conducted that presented only an overall p-value. The results in Sweden did not find a 
positive association between childhood leukemia and nuclear sites (47). An Israeli 
nuclear generator was not included because only incidence rates were reported. Similar 
to Sweden, no excess cases were found (48). The inclusion of the Swedish and Israeli 
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sites would have likely decreased the meta-rates, although it is difficult to detennine 
whether that drop would have affected the statistical significance. It would also have 
been beneficial to include nuclear sites from the former Soviet Union, China, and other 
countries with nuclear facilities. However, that was not possible and the consistently 
significant results that were found in the meta-analysis cannot be ignored. 
Model Limitations: 
The unadjusted model makes no attempt at adjusting for study size and is simply 
the sum of the observed cases or deaths divided by the sum of the expected cases or 
deaths. Fixed effects models weight studies based on sample size. Thus, a larger study 
has more influence on the overall effect than smaller studies. This may be problematic 
when studying childhood leukemia, since a possible risk factor is population density. 
The EUROCLUS study suggests there might be an increase in cases in areas of 
intermediate population density (148). Therefore, weighting based on sample size has the 
unintended result of giving more influence to studies that may cover areas of higher 
population density, a possible risk factor. Another disadvantage is the underlying 
assumption that each study is estimating the same treatment effect and the treatment 
effect differs solely as a result of random sample variability (149-150). The assumption 
is highly unlikely for reasons explained throughout this document. Formal tests for 
heterogeneity were carried out to test the underlying assumptions of fixed effects models. 
The results were not significant but such tests suffer from low power (131). Due to the 
low power of the tests, we decided to go forward with random effects models. Random 
effects models have their own limitations. An important limitation is the assumption that 
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the studies included in the meta-analysis derive from a hypothetical random distribution 
that can be described by a common variance (149,151). Another potential problem is 
random effects models give greater weight to smaller studies than fixed effects models. 
Smaller studies may be more likely to reflect certain biases, including publication bias; 
and consequently, will affect the summary estimate (152,138,149). Last, distributions 
from random effects models often have no empirical, epidemiological, or biologic 
justification (138). 
Meta-Analysis Limitations 
Caution must be used when interpreting these results. The meta-analysis was able 
to show an increase in childhood leukemia near nuclear facilities, but could not support a 
hypothesis to explain the excess. Each type of model utilized has limitations. However, 
the fixed effects and random effects models often produced equivalent or nearly 
equivalent results making model selection" less critical. Dose-response studies" do not 
support the excess rates found near nuclear facilities, although it may be that we do not 
understand the risk from interactions of radiation and chemicals that may be emitted from 
a site. Several studies have also shown the rates of childhood leukemia pre and post 
start-up of operation remained consistent, even when rates were greater than one. Nor 
can we rule out the possibility of an infectious origin, which has been supported by many 
studies. Even in consideration of the limitations of this meta-analysis, it cannot be 
ignored that the majority of studies have found elevated rates, although not usually 
statistically significant. 
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Although a systematic approach was used to identify studies that met the criteria 
of interest, the detennination of the inclusion rules is subjective and may not be the best 
set of rules; however, clearly defining the rules allows other researchers to criticize or 
suggest better methods. Similar to other common statistical methods, statistics in meta-
analysis serve as a 'pattern recognition device' and cannot determine causation (138). 
Meta-analysis is a tool to aid researchers, but it is the researchers that must describe 
biologic plausibility. Nor does a meta-analysis directly evaluate the bias of the 
individual studies. A few ad hoc methods exist to adjust for quantifiable bias, but these 
are far from full proof. Many unquantifiable biases may exist that contribute to 
heterogeneity (138). 
Spatial and Temporal Analysis Near Pickering Nuclear Generator 
One of the goals of this dissertation was to gain a better understanding of the 
temporal and spatial relationship between childhood leukemia and Pickering Nuclear 
Generator (PNG). The census subdivisions of Pickering and Ajax, which includes PNG, 
had an SIR 0.99 for the 0-14 age group from 1971-2000. Clarke reported a statistically 
non-significant SIR of 1.15 in the <25 km area, 1971-1986. Several differences exist 
between the two studies: 
1. Clarke used residence at birth for cases. We were unable to obtain birth records 
and therefore, relied on residence at diagnosis. If we look only at residence at 
diagnosis for the time-period 1971-1986, similar to the time-period used by 
Clarke, the SIR for Pickering/Ajax and the original 6 census subdivisions 
(including Pickering/Ajax) are 0.78 and 0.86, respectively. If one were testing 
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whether there is an association between paternal or in utero radiation exposure 
and childhood leukemia, then residence at birth would serve as a better indicator 
than residence at diagnosis. These hypotheses have been tested in past studies. 
Gardner found a strong association between paternal radiation exposure and 
leukemia in offspring near Sellafield (66). McLaughlin conducted a similar study 
in Ontario but was unable to find an association (82); nor have other studies 
supported Gardner's findings (153). The association between in utero exposure to 
ionizing radiation and childhood leukemia has been supported by various studies 
and is considered a known risk factor (98,107,154). However, the question 
remains as to whether the possible low levels of radiation received in utero, to 
residence near nuclear facilities would be significant enough to increase risk of 
developing childhood leukemia. Studies to date, suggest the dose to fetus would 
be too low to account for excess risk (8,109,25). 
2. The focus of our study concentrated on residents primarily within 12.5 km, which 
we considered more likely to be at risk. Although it would have been preferable 
to compare the results of the 12.5 km area of Pickering/Ajax to the 25 Ian area 
containing '6 census subdivisions (including Pickering/Ajax), it was not possible 
due to Scarborough dissolving in 1998 and becoming part of Toronto. However, 
if only 1971-1997 were analyzed, the SIR for Pickering/Ajax and the original 6 
census subdivisions are 0.96 and 0.94, respectively. 
3. A spatial analysis within 25 km is not possible because Darlington Nuclear 
Generator began operation in 1991 approximately 35 km east ofPNq-. Although 
unlikely when considering prevailing wind directions, bands greater than 15 km 
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from PNG may be affected by radiation emitted from Darlington, compromising 
the use of distance as a surrogate for exposure from PNG. Further, the 
enumeration area census data used in the spatial analysis originated in 1986, not 
allowing for a meaningful spatial analysis to be conducted from 1986-1990, the 
period before Darlington began operation. We were able to calculate an overall 
SIR for 1971-1990: Pickering/Ajax and the original 6 census subdivisions 
(including Pickering/Ajax) are 0.96 and 0.99, respectively. 
Smooth moving SIRs have the advantage of avoiding the bias of selecting arbitrary 
time intervals while allowing the researcher to determine whether excess cases, if present, 
were dispersed over time or clustered near a certain time point (138). In the case of 
Pickering/Ajax, moving SIRs consistently near one indicate that exposure to children 
near PNG from radiation has not led to excess cases above the provincial average. One 
control area, the census subdivisions of Niagara Falls/WeIland/Thorold had unexpectedly 
high SIRs that persisted through the entire study period. However, Niagara County, the 
census division that contains Niagara Falls/WeIland/Thorold, as a whole had moving 
SIRs remain near one. Further research is needed in the Niagara Falls area. Although 
control areas were only used for non-statistical comparisons, the selection of control 
areas based on population data at only one time point when a thirty-year period is studied 
is a limitation. It is essentially a snapshot in time that does not necessarily reflect 
temporal population growth patterns. 
Ideally, in spatial analysis, exposure zones would be created based on dispersion 
models that take into account many parameters such as type and amount of substance, 
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median of exposure (Le. air or water), stack heights, wind direction and speed, and terrain 
(117). Unfortunately, the aforementioned data is often not available in ecological studies, 
leaving distance as the best surrogate for exposure. The availability of wind data allowed 
us to construct exposure zones that are based on additional infonnation other than rely 
solely on distance. The Score Test did not find an association between distance and PNG; 
nor was an association found when exposure zones were created based on prevalent wind 
direction. The inability to find an association may be because no association exists or the 
study lacks power to find an association. 
Explaining Elevated Rates Near Nuclear Facilities 
Although the meta-analysis found consistently elevated rates for all stratification 
levels, it is important to note that there are many questions still to be answered; and 
several hypotheses have been proposed to explain the excess of childhood leukemia in 
the vicinity of nuclear facilities, including environmental exposure, paternal exposure, 
and viral transmission. 
Environmental exposure to radiation is a known risk factor for leukemia (2-3,5). 
However, there is a question as to whether the amount of exposure received by children 
living near nuclear sites is sufficient to increase risk. Authors that have used emissions 
data from nuclear facilities and conducted dose-response studies have consistently found 
that radiation discharge was too low to account for the excess cases of childhood 
leukemia (8,108-109,25). It also appears highly unlikely that preconception paternal 
exposure to radiation increases the risk of leukemia to the child, an original hypothesis 
from the Sellafield studies (79-82,103). Researchers have studied whether certain 
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lifestyles could lead to increased risk near nuclear facilities due to environmental 
contamination (66,81,103). Although significant results were found with use of beaches 
in the areas of Dounreay (81) and La Hague (103), it is difficult to determine the dose 
attributed to use of beaches and the relationship to childhood leukemia (7). 
Several problems arise when conducting dose-response studies In an 
epidemiological setting. Determining an individual's dose relies not only on knowledge 
of facility emissions and geographic parameters but also the lifestyles of the individuals 
in the population. Another difficulty is that the expected dose-response relationship is 
established in an external population and exposure between the population of interest and 
the external population may differ. For example, many of the dose-response studies 
relied on the Life Span Study of Atomic Survivors (105) and the Oxford Survey of 
Childhood Cancers (107). The Life Span Study was a single acute high dose exposure 
and the Oxford Survey of Childhood Cancers was intennittent high doses; whereas, the 
potential exposure from a nearby nuclear facility is most likely a continuous low dose. It 
may also be that there are interactions between two or more environmental exposures that 
we are yet to understand. Gibson and Wheldon believe there may be a synergistic effect 
between radiation and chemicals that could increase the risk of developing childhood 
leukemia (119-120). 
If the amount of exposure were too low to cause the excess risk, then one would 
expect that the rates remained consistent before and after the start-up of a nuclear facility. 
Several studies were able to calculate rates for regions before and after a nuclear facility 
began operation (11-12,45,143-144,17). Rates generally remained unchanged pre and 
post start-up, even in regions with elevated rates. For example, Jablon analyzed nuclear 
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sites in the USA and found that SMRs for childhood leukemia in the 0-9 age group were 
higher before start-up when compared to after start-up. For the four facilities that 
incidence data were available, three sites had higher SIRs after start-up than before start-
up; however, rates were above one for both time periods (143). Other authors compared 
regions that were considered for the installation of a nuclear facility and regions that had 
an existing nuclear facility. Both types of areas had excess mortality from leukemia and 
Hodgkin's Disease. It was suggested that there might be an unidentified risk factor 
shared by these regions, other than environmental radiation (22). 
A hypothesis that has been well received is the possibility of an infectious origin 
to childhood leukemia caused by population mixing (6). Among those hematologic 
cancers that are associated with infectious agents are Burkitt lymphoma and adult T-cell 
leukemia (7,155,84). Kinlen hypothesized that "childhood leukemia may be a rare 
response to an unidentified mild or subclinical infection, the transmission of which is 
facilitated when large numbers of people come together, particularly from a variety of 
origins." Further, this herd immunity may allow individuals in a population to be infected 
with the virus, but not develop the disease. When this population is mixed with another 
population that has not previously been exposed to the virus, individuals in the 
susceptible population may develop the disease (86). Although the possibility of a viral 
agent is suggested by several studies (86,89-91,95-96), an infectious agent has yet to be 
identified. 
Potential Bias 
Potential Bias and Concerns with Studies of Radiation from Nuclear Facilities and 
Childhood Leukemia. 
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1. Case Ascertainment-A few of the smaller studies did not address the 
completeness of case ascertainment. The issue was generally seen in small 
follow-up studies, but should always be addressed. 
2. Types of leukemia-It is always preferable when studies include information 
on which types of leukemia are included in the analysis. Only rarely do 
studies break down rates by different types (see attached study table). The 
most dominant leukemia below the age of 25 is ALL, followed by AML, and 
last is CML (expecting less than 1 case per 100,000). CLL is not found in 
children. Although all three types may be caused by radiation, it remains to 
be seen whether, radiation increases the risk of one type of these leukemias 
more than the others in the childhood age groups. 
3. Age-At all age groups through 25, ALL is the dominant leukemia, followed 
by AML, and last is CML (see Table 1). 
4. MUltiple testing-Multiplicity becomes an issue when a study calculates 
mUltiple rates. It is quite common for these studies to calculate rates for 
mUltiple age groups, areas, and sites with no adjustment for mUltiple 
comparisons. Although it is common for epidemiological studies to not adjust 
for mUltiple testing, at the very least, the studies should mention that no 
adjustments were made. In only a few studies included in the background, 
was there mention of the issue of mUltiplicity. 
5. Over Exposure-Often, multiple studies examine the same site where a 
significant cluster was found. The follow-up studies may: 
• use a different statistic (i.e. SIR or comparison to control area), 
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• a slightly modified age group that often includes much of the same 
population that was in the original studies, 
• or slightly modified area that also may include much of the same area as 
the original study, 
• or simply additional years of data (presenting overall results that include 
the original years). 
When reviewing the literature, it is important to keep in mind that although 
there may be many significant results in multiple publications, in reality, they 
are on the same population or just a slightly modified population. 
6. A posteriori studies-A few studies were conducted after knowledge of a 
cluster of leukemias had already been suggested. This was true in the original 
Sellafield study and also when a second study was done on the same 
population, or subset of that population where a cluster had been identified. A 
posteriori studies are not able to test a hypothesis but rather confirm the 
existence of a cluster. This limitation should be mentioned by the authors of 
these studies, but was not always done. 
7. Foreign language publications-In a few studies included in the literature 
review section, it was not possible to read the entire publication because only 
the abstract was in English. Without reading the publication, it is difficult to 
determine whether the study was conducted at a high level or may contain 
bias. This was the case for the Hungarian study (51). 
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Ecological Fallacy 
One pitfall that all studies designed to examine geographic patterns of disease 
must avoid is ecological fallacy, that is, the bias that may occur when concluding that 
elevated risks based on aggregate data represent the possible elevated risks that exists at 
the individual level. Simply said, it is the individuals not the geographic area that 
contracts the disease. For example, one could say, correctly, in a study that found a SIR 
of 1.5 that 50% excess cases are expected in that area. However, it would be incorrect to 
state that all individuals living in the study area are equally at an increased risk of 
developing the disease. It may be that within the area of study, only those residing very 
close to the nuclear facility are at elevated risk or even an individual's particular lifestyle 
that increases risk. The majority of publications on the association of childhood leukemia 
and nuclear facilities are designed to calculate an overall incidence rate for an area and do 





The meta-analysis was conducted to combine and statistically analyze the many 
studies of childhood leukemia in the vicinity of nuclear facilities. Our focus was on 
studies that calculated SMRs or SIRs for individual nuclear sites. Due to variability 
between studies in defining age and geographic zones, eight separate analyses were 
perfonned based on age and zone stratification levels. One hundred and forty-six sites 
were used in at least one analysis. Unadjusted models, fixed effects models, and random 
effects models were used for each of the eight analyses. Meta-rates greater than one were 
found in all models at all stratification levels. Further, statistical significance at 95% 
confidence intervals was often achieved. Within geographic zones (as established by the 
meta-analysis), the 0-9 age group experienced higher rates than the 0-25 age group. 
There does not appear to be publication bias in the meta-analysis. 
Caution must be used when interpreting these results. The meta-analysis was able 
to show an increase in childhood leukemia near nuclear facilities, but could not support a 
hypothesis to explain the excess. Each type of model utilized has limitations. However, 
the fixed effects and random effects models often produced equivalent or nearly 
equivalent results making model selection less critical. Dose-response studies do not 
support the excess rates found near nuclear facilities, although it may be that we do not 
understand the risk from interactions of radiation and chemicals that may be emitted from 
a site. Several studies have also shown the rates of childhood leukemia pre and post 
start-up of operation remained consistent, even when rates were greater than one. Nor 
can we rule out the possibility of an infectious origin, which has been supported by many 
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studies. Even in consideration of the limitations of this meta-analysis, it cannot be 
ignored that the majority of studies have found elevated rates, although not usually 
statistically significant. 
Spatial and Temporal Analysis Near Pickering Nuclear Generator 
The analysis was designed to better understand the temporal and spatial 
relationship between radiation from PNG and childhood leukemia. The analysis used 
much of the same data as Clarke (11-12), and therefore, could only be considered 
exploratory. We attempted to use data as similar to Clarke as possible, but there were 
limitations. For example, Clarke used residence at birth while we used residence as 
diagnosis. Scarborough, the most populated census subdivision included in the Clarke 
analysis has since dissolved and become part of Toronto. The above mentioned data 
limitations were not of great concern because we were focusing on post conception 
exposure, and due to prevailing wind directions, Scarborough was believed to receive 
insignificant exposure. 
Most studies of nuclear radiation and childhood leukemia simply calculate an 
SIR or SMR for a given time frame, usually limited by data availability and without 
consideration of geographic distribution. However, we believe by using smoothed 
moving rates through time and a spatial analysis allows for a more comprehensive 
description of disease patterns. No apparent relationship between childhood leukemia 
and PNG was detected with the methods used. In the temporal analysis, moving SIRs 
remained near one for the entire time-period for the census subdivisions of Pickering and 
Ajax. Nonsignificant p-values were produced in the spatial analysis. The highest rates 
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were found in the innermost and outermost bands, with the highest population in the 
outer bands. 
Future Work 
The focus of future work should include spatial and temporal analyses perhaps 
focusing on the 0-9 age group. In a temporal analysis, the use of moving windows for 
rates would allow researchers to understand whether rates remain consistent over time or 
experience temporal peaks (7). To understand the spatial relationship between childhood 
leukemia and nuclear facilities, multiple zones should be established and analyzed with 
basic trend tests or specific spatial statistics, such as the Score Test of Lawson and Waller 
(156) or Stone's Test (157). It is understood that the limitations of data availability by 
geostatistical units often does not allow or makes it difficult to establish exposure zones 
close to a nuclear site. However, every effort should be made to establish multiple zones. 
Unfortunately, the low populations normally found near nuclear facilities may not allow 
for adequate power for spatial analysis. Including multiple sites will increase sample size 
and power (139). 
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7. APPENDICES 
A ~en ·PI dix A - Sit, d in Met 1 
10 A1 A2 A3 A4 AS A6 A7 AS Site Author Country End· Age Zone Duration Obs Exp Rate 95%CI 
point (km) 
1 X X Aldermaston COMARE III Britain I 0·24 0·16 20 82 70.09 1.17 0.93,1.45 
2 X X Aldermaston COMARE III Britain M 0-24 0·16 22 55 67.9 0.81 0.61,1.05 
3 X X iAldermaston COMARE III Britain I 0·9 0-16 20 51 42.15 1.21 0.9,1.6 
4 X X iAldermaston COMARE III Britain M 0-9 0·16 22 29 28.16 1.03 0.69,1.49 
5 X X X X ~mersham Goldsmith Britain M 0-9 0·16 10 35 28.34 1.24 0.86,1.72 i 
6 X X X X ~mersham Goldsmith Britain I 0-9 0-16 10 60 40.63 1.48 1.13,1.9 
7 X X Berkeley Baron Britain M 0-14 0-8 17 14 8.74 1.6 0.88,2.69 
I 
8 X X Berkeley Goldsmith Britain M 0-9 0-16 10 4 6.46 0.62 0.17, 1.59 i 
9 X X X X Berkeley Goldsmith Britain I 0-9 0-16 10 9 11.72 0.77 0,35, 1.46 
10 X X Bradwell Baron Britain M 0-14 0-8 17 8 3.98 2.01 0,87,3.96 
11 X X Bradwell Goldsmith Britain M 0-9 0-16 10 4 2.35 1.7 0.46,4.36 
12 X X X X Bradwell Goldsmith Britain I 0-9 0-16 10 4 6.53 0.61 0,17,1.57 
13 Burghfield Roman Britain I 0-14 0-10 14 38 23.86 1.59 1.13,2.19 
14 Burghfield Roman Britain I 0-4 0-10 14 27 12.19 2.21 1.46,3.22 
15 X X X X Capenhurst Goldsmith Britain M 0-9 0-16 10 21 20.04 1.05 0.65, 1.6 
16 X X X X Capenhurst Goldsmith Britain I 0-9 0-16 10 29 28.5 1.02 0.68,1.46 
17 X X X X Dungeness Goldsmith Britain M 0-9 0-16 10 2 0.7 2.84 0.34,10.23 
18 X X X X Dungeness Goldsmith Britain I 0-9 0-16 10 2 1.01 1.98 0.24,7.15 
19 X X Harwell COMARE III Britain I 0-14 0-10 12 4 5.87 0.68 0.19, 1.74 
20 X X X X Harwell Goldsmith Britain M 0-9 0-16 10 3 5.4 0.56 0.11, 1.62 
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Appendix A - continued 
10 A1 A2 A3 A4 A5 A6 A7 AS Site Author Country End- Age Zone Duration Obs Exp Rate 95%CI point (km). 
21 X X Harwell Goldsmith Britain I 0-9 0-16 10 4 7.8 0.51 0.14, 1.31 
22 X X Hinkley Baron Britain M 0-14 0-8 17 9 7.17 1.26 0.57,2.38 
23 X Hinkley Ewing Britain I 0-24 0-12.5 23 13 7.91 1.64 0.88,2.81 
24 X Hinkley Ewing Britain I 0-24 District 23 100 83.47 1.2 0.97, 1.46 
25 X X Hinkley Goldsmith Britain M 0-9 0-16 10 5 1.89 2.65 0.85,6.14 
26 X X Hinkley Goldsmith Britain I 0-9 0-16 10 9 6.11 1.47 0.67,2.8 
27 X X X X Sellafield Goldsmith Britain M 0-9 0-16 10 3 2 1.5 0.31,4.38 
28 X X X X Sellafield Goldsmith Britain t 0-9 0-16 10 8 4.18 1.91 0.83,3.77 
29 X X Sizewe" Baron Britain M 0-14 0-8 17 1 0.76 1.32 0.03,7.33 
30 X X Sizewell Goldsmith Britain M 0-9 0-16 10 2 1.11 1.8 0.22,6.51 
31 X X X X Sizewell Goldsmith Britain I 0-9 0-16 10 3 2.06 1.46 0.3,4.26 
32 X X X X Spingfields Goldsmith Britain M 0-9 0-16 10· 20 14.56 1.37 0.84,2.12 
33 X X X X Spingfields Goldsmith Britain I 0-9 0-16 10 28 25.2 1.11 0.74,1.61 
34 X X Trawsfynydd Baron Britain M 0-14 0-8 17 1 0.64 1.56 0.04,8.71 
35 X X Trawsfynydd Goldsmith Britain M 0-9 0-16 10 1 0.16 6.1 0.15,33.97 
36 X X X X Winfrith Goldsmith Britain M 0-9 0-16 10 4 3.89 1.03 0.28,2.63 
37 X X X X Winfrith Goldsmith Britain I 0-9 0-16 10 9 7.05 1.28 0.58,2.42 
38 X X X X Wylfa Goldsmith Britain M 0-9 0-16 10 2 0.56 3.56 0.43,12.88 
39 X Chalk River McLaughlin Canada I 0-14 County 23 16 23 0.7 0.4, 1.13 
40 X Chalk River McLaughlin Canada M 0-14 County 38 17 23.9 0.71 0.41,1.14 
41 X Chalk River McLaughlin Canada I 0-4 County 22 8 11.4 0.7 0.3,1.38 
42 X Chalk River McLaughlin Canada M 0-4 County 37 8 10.4 0.77 0.33, 1.52 
43 X Douglas Point McLaughlin. Canada I 0-14 County 20 9 7.2 1.25 0.57,2.37 
44 X Douglas Point McLaughlin Canada M 0-14 County 21 5 3.2 1.56 0.51,3.65 
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A p-en ·Pl dixA f d 
10 A1 A2 A3 A4 AS A6 A7 A8 Site Author Country End- Age Zone Duration Obs Exp Rate 9S%CI point (km) 
45 X Douglas Point McLaughlin Canada I 0-4 County 19 6 4.6 1.3 0.48,2.84 
46 X Douglas Point McLaughlin Canada M 0-4 County 20 3 1.6 1.88 0.39,5.48 
47 X Elliot lake McLaughlin Canada I 0-14 County 23 43 33.7 1.28 0.92,1.72 
48 X Elliot lake McLaughlin Canada M 0-14 County 34 38 27.6 1.38 0.97,1.89 
49 X Elliot Lake McLaughlin Canada I 0-4 County 22 18 17.5 1.03 0.61, 1.63 
50 X Elliot Lake McLaughlin Canada M 0-4 County 33 14 11.6 1.21 0.66,2.02 
51 X Pickering Mclaughlin Canada I 0-14 County 16 75 65.7 1.14 0.9,1.43 
52 X Pickering McLaughlin Canada M 0-14 County 17 33 25.7 1.28 0.88,1.8 
53 X Pickering Mclaughlin Canada I 0-4 County 15 52 43.1 1.21 0.9,1.58 
54 X Pickering McLaughlin Canada M 0-4 County 16 17 13 1.31 0.76,2.09 
55 X Port Hope McLaughlin Canada I 0-14 County 23 21 18.8 1.12 0.69,1.71 
56 X Port Hope McLaughlin Canada M 0-14 County 38 20 17.5 1.14 0.7,1.77 
57 X Port Hope McLaughlin Canada I 0-4 County 22 14 9.8 1.43 0.78,2.4 
58 X Port Hope McLauohlin Canada M 0-4 County 37 12 8.1 1.48 0.77,2.59 
59 X X Greifswald Michaelis East Germany I 0-14 0-15 10 3 2.69 1.12 0.23,3.26 
60 X X Rheinsberg Michaelis East Germany I 0-14 0-15 10 2 1.62 1.23 0.15,4.46 
61 X X Rossendorf Michaelis East Germany I 0-14 0-15 10 14 10.73 1.3 0.71,2.19 
62 X X Bugey Hattchouel France M 0-25 0-16 19 8 11.16 0.72 0.31,1.41 
63 X X Chinon Hattchouel France M 0-25 0-16 22 8 8.88 0.9 0.39,1.78 
64 X X Chooz Hattchouel France M 0-25 0-16 22 9 5.65 1.59 0.73,3.02 
65 X X Cruas Hattchouel France M 0-25 0-16 7 3 3.3 0.91 0.19,2.66 
66 X X Dampierre Hattchouel France M 0-25 0-16 10 2 2.44 0.82 0.1, 2.96 
67 X X Fessenheim Hattchouel . France M 0-25 0-16 13 2 2.92 0.68 0.08,2.47 
68 X X Gravelines Hattchouel France M 0-25 0-16 10 11 10.2 1.08 0.54, 1.93 
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A flen ,PI dixA f d 
10 A1 A2 A3 A4 A5 A6 A7 A8 Site Author Country End- Age Zone Duration Obs Exp Rate 95%CJ 
point (km) 
69 X La Hague Veil France I 0-24 0-10 15 4 1.4 2.86 0.78,7.32 
70 X La Hague rveil France I 0-24 0-35 15 25 22.8 1.1 0.71, 1.62 
71 X La Hague ~eil France M 0-24 0-35 19 21 23.6 0.89 0.55,1.36 
72 X La Hague Hattchouel France M 0-25 0-16 22 2 5.36 0.37 0.05,1.35 
73 X La Hague Veil France I 0-4 0-10 15 1 0.3 3.33 0.08,18.57 
74 X La Hague Veil France I 0-4 0-35 15 9 5 1.8 0.82,3.42 
75 X La HaJJue Veil France M 0-4 0-35 19 5 4.77 1.05 0.34,2.45 
76 X X Marcoule Hattchouel France M 0-25 0-16 22 19 23.3 0.81 0.49, 1.27 
77 X X St. Laurent Hattchouel France M 0-25 0-16 21 5 6.57 0.76 0.25,1.78 
78 X Genkai Iwasaki Japan M 0-14 36 10 1 0.38 2.63 0.07,14.66 
79 X Mihama Iwasaki Japan M 0-14 152.24 15 2 0.97 2.06 0.25,7.45 
80 X Naraha Iwasaki Ja~an M 0-14 103.45 5 2 0.16 12.27 1.51,45.15 
81 X Takahama Iwasaki Japan M 0-14 72.07 10 1 0.54 1.85 0.05,10.32 
82 X Tokai Iwasaki Japan M 0-14 37.48 15 3 2.75 1.09 0.22,3.19 
83 X Tsuruga Iwasaki Japan M 0-14 250.74 15 4 5.25 0.76 0.21,1.95 
84 X X Chapel Cross Heasman Scotland I 0-24 0-12.5 17 5 3.65 1.37 0.44,3.2 
85 X Dounreay COMARE II Scotland I 0-24 0-12.5 17 5 1.53 3.26 1.06,7.63 
86 X Dounreay COMARE II Scotland I 0-24 0-25 17 6 2.95 2.03 0.75,4.43 
87 X Faslane Hole Scotland I 0-14 Postcodes 22 5 4.2 1.19 0.39,2.78 
88 X X Holy Loch Heasman Scotland I 0-24 0-12.5 17 18 15.01 1.2 0.71,1.9 
89 X X Hunterston Heasman Scotland I 0-24 0-12.5 17 14 10.21 1.37 0.75,2.3 
90 X X Rosyth Heasman Scotland I 0-24 0-12.5 17 30 30.62 0.98 0.66, 1.4 
91 X ~ndujar Lopez-Abente Spain M 0-24 0-15 19 13 10.57 1.23 0.65,2.1 
92 X ~ndujar Lopez-Abente Spain M 0-24 0-30 19 30 22.38 1.34 0.9,1.91 
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A Lp1 len dixA f d 
10 A1 A2 A3 A4 AS A6 A7 AS Site Author Country End~ Age Zone Duration Obs Exp Rate 9S%CI point (km) 
93 X Aseo Lopez-Abente S~ain M 0·24 0·15 19 1 1.14 0.88 0.02,4.89 
94 X Aseo Lopez-Abente Spain M 0-24 0-30 19 2 2.6 0.77 0.09,2.78 
95 X Cofrentes Lopez-Abente Spain M 0-24 0-30 19 2 2.04 0.98 0.12,3.54 
96 X Cuidad Rodrigo Lopez-Abente Spain M 0-24 0-15 19 3 1.72 1.74 0.36,5.1 
97 X Cuidad Rodrigo Lopez-Abente Spain M 0-24 0-30 19 3 3.03 0.99 0.2,2.89 
98 X EI Cabril Lopez-Abente Spain M 0-24 0-30 19 7 6.08 1.15 0.46,2.37 
99 X Garona Lopez-Abente Spain M 0-24 0-15 19 1 0.45 2.22 0.06,12.38 
100 X Garona Lopez-Abente Spain M 0-24 0-30 19 10 9.8 1.02 0.49, 1.88 
101 X Juzbado Lopez-Abente Spain M 0-24 0-15 19 1 0.77 1.3 0.03,7.23 
102 X Juzbado Lopez-Abente Spain M 0-24 0-30 19 5 8.06 0.62 0.2, 1.45 
103 X La Haba Lopez-Abente Spain M 0-24 0-15 19 2 2.13 0.94 0.11,3.39 
104 X La Haba Lopez-Abente Spain M 0-24 0-30 19 16 14.68 1.09 0.62, 1.77 
105 X Vandellos Lopez-Abente Spain M 0-24 0-15 19 3 1.33 2.26 0.47,6.6 
106 X ~andellos Lopez-Abente Spain M 0-24 0-30 19 9 12.16 0.74 0.34,1.41 
107 X Zorita Lopez-Abente Spain M 0-24 0-15 19 2 0.98 2.05 0.25,7.37 
108 X ~orita Lopez-Abente Spain M 0-24 0-30 19 4 3.64 1.1 0.3,2.81 
109 X Arkansas Jablon USA M 0-19 County 11 3 2.33 1.29 0.27,3.76 
110 X Arkansas Jablon USA M 0-9 County 11 2 1.13 1.77 0.21,6.39 
111 X Big Rock Point Jablon USA M 0-19 County 23 6 7.34 0.82 0.3, 1.78 
112 X Big Rock Point Jablon USA M 0-9 County 23 4 4.17 0.96 0.26,2.46 
113 X Brown's Ferry Jablon USA M 0-19 County 12 2 2.74 0.73 0.09,2.64 
114 X Brunswick Jablon USA M 0-19 County 10 2 0.94 2.13 0.26,7.69 
115 X Brunswick Jablon USA M 0-9 County 10 2 0.94 2.13 0.26,7.69 
116 X Calvert Cliffs Jablon USA M 0-19 County 11 2 2.05 0.98 0.12,3.52 
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A ~PI flen dixA d 
10 A1 A2 A3 A4 AS AS A7 AS Site Author Country End- Age Zone Duration Obs Exp Rate 95%CI point (km) 
117 X Calvert Cliffs Jablon USA M 0-9 County 11 1 0.99 1.01 0.03,5.63 
118 X Cook Jablon USA M 0-19 County 10 5 9.06 0.55 0.18, 1.29 
119 X Cook Jablon USA M 0-9 County 10 2 4.44 0.45 0.05,1.63 
120 X Cooper Station Jablon USA M 0-19 County 11 1 0.76 1.32 0.03,7.33 
121 X Crystal River Jablon USA M 0-19 County 8 1 0.79 1.27 0.03,7.05 
122 X Davis Besse Jablon USA M 0-19 County 8 1 0.75 1.33 0.03,7.43 
123 X Davis Besse Jablon USA M 0-9 County 8 1 0.75 1.33 0.03,7.43 
124 X Dresden Jablon USA M 0-19 County 25 49 65.66 0.75 0.55,0.99 
125 X Dresden Jablon USA M 0-9 County 25 32 39.51 0.81 0.55,1.14 
126 X Duane Arnold Jablon USA M 0-19 County 11 13 11.6 1.12 0.6,1.92 
127 X Duane Arnold Jablon USA I 0-19 County 11 31 22.52 1.38 0.94, 1.95 
128 X Duane Arnold Jablon USA M 0-9 County 11 4 5.71 0.7 0.19, 1.79 
129 X Duane Arnold Jablon USA I 0-9 County 11 17 13.49 1.26 0.73,2.02 
130 X Farley Jablon USA M 0-19 County 8 3 3.51 0.85 0.18,2.5 
131 X Farley Jablon USA M 0-9 County 8 1 1.75 0.57 0.01,3.18 
132 X Fermi Jablon USA M 0-19 County 22 26 24.9 1.04 0.68, 1.53 
133 X Fermi Jablon USA M 0-9 County 22 15 14.42 1.04 0.58,1.72 
134 X Fernald Jablon USA M 0-19 County 34 337 345.47 0.98 0.87,1.09 
135 X Fernald Jablon USA M 0-9 County 34 218 220.2 0.99 0.86,1.13 
136 Fort Calhoun Jablon USA M 0-19 County 12 2 1.09 1.83 0.22,6.63 
137 Fort Calhoun Jablon USA I 0-19 County 12 4 1.28 3.13 0.85,8 
138 X Fort Calhoun Jablon USA M 0-9 County 12 2 1.09 1.83 0.22,6.63 
139 X Fort Calhoun Jablon USA I 0-9 County 12 4 1.28 3.13 0.85,8 
140 X Fort St Vrain Jablon USA M 0-19 County 9 .. _--20 20.33 0.98 0.6, 1.52 
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A flen ·P] dixA f d 
ID A1 A2 A3 A4 A5 A6 A7 AS Site Author Country End- Age Zone Duration Obs Exp Rate 95%CI point (km) 
141 X Fort St Vrain Jablon USA M 0-9 County 9 7 9.59 0.73 0.29,1.S 
142 X Ginna Jablon USA M 0-19 County 16 8 9.48 0.84 0.36,1.66 
143 X Ginna Jablon USA M 0-9 County 16 2 5.13 0.39 O.OS, 1.41 
144 X Haddam Neck Jablon USA M 0-19 County 18 19 14.89 1.28 0.77,1.99 
145 X Haddam Neck Jablon USA I 0-19 County 18 24 2S.38 0.95 0.61,1.41 
146 X Haddam Neck Jablon USA M 0-9 County 18 9 7.89 1.14 0.52,2.17 
147 X Haddam Neck Jablon USA I 0-9 County 18 16 16.49 0.97 0.55,1.S8 
148 X Hallam Jablon USA M 0-19 County 23 45 35.83 1.26 0.92,1.68 
149 X Hallam Jablon USA M 0-9 County 23 29 20.14 1.44 0.96,2.07 
150 X Hanford Jablon USA M 0-19 County 35 63 54.58 1.15 0.89, 1.48 
151 X Hanford Jablon USA M 0-9 County 35 45 35.43 1.27 0.93,1.7 
152 X Hatch Jablon USA M 0-19 County 11 1 1.2 0.83 0.02,4.64 
153 X Hatch Jablon USA M 0-9 County 11 1 1.2 0.83 0.02,4.64 
154 X Humboldt Bay Jablon USA M 0-19 County 22 21 17.74 1.18 0.73,1.81 
155 X Humboldt Bay Jablon USA M 0-9 County 22 8 10 0.8 0.35,1.S8 
Idaho Natnl 
156 X Engineer Lab Jablon USA M 0-19 County 35 20 20.33 0.98 0.6,1.S2 
Idaho Natnl 
157 X Engineer Lab Jablon USA M 0-9 County 35 13 13.4 0.97 0.52,1.66 
158 X I ndian Point Jablon USA M 0-19 County 23 201 189.24 1.06 0.92,1.22 
159 X Indian Point Jablon USA M 0-9 County 23 122 106.09 1.15 0.95,1.37 
La Cross 
160 X (Genoa) Jablon USA M 0-19 County 18 6 3.19 1.88 0.69,4.09 
La Cross 
161 X l(Genoa) Jablon USA M 0-9 Coun~ 18 1 1.69 0.59 0.01,3.3 
162 X Maine Yankee Jablon USA M 0-19 County 13 5 4 1.25 0.41,2.92 
163 X Maine Yankee Jablon USA M 0-9 County 13 ~- 2.12 1.89 0.51,4.83 
159 
A ~P] Jen dixA ti d 
10 A1 A2 A3 A4 A5 A6 A7 AS Site Author Country End- Age Zone Duration Obs Exp Rate 95%CI point (km) 
164 X McGuire Jablon USA M 0-19 County 4 3 8.82 0.34 0.07,0.99 
165 X McGuire Jablon USA M 0-9 County 4 1 4.17 0.24 0.01, 1.34 
166 X Millstone Jablon USA M 0-19 County 15 29 22.84 1.27 0.85,1.82 
167 X Millstone Jablon USA I 0-19 County 15 58 42.82 1.35 1.03,1.75 
168 X Millstone Jablon USA M 0-9 County 15 17 11.72 1.45 0.84,2.32 
169 X Millstone Jablon USA I 0-9 County 15 44 28.39 1.55 1.13,2.08 
170 X Monticello Jablon USA M 0-19 County 14 4 8.12 0.49 0.13,1.26 
171 X Monticello Jablon USA M 0-9 County 14 2 4.35 0.46 0.06,1.66 
172 X Mound Jablon USA M 0-19 County 35 292 294.1 0.99 0.88, 1.11 
173 X Mound Jablon USA M 0-9 County 35 189 189 1 0.86,1.15 
174 X Nine Mile Point Jablon USA M 0-19 County 16 11 13.07 0.84 0.42, 1.51 
175 X Nine Mile Point Jablon USA M 0-9 County 16 6 6.82 0.88 0.32, 1.91 
176 X North Anna Jablon USA M 0-19 County 7 2 1.53 1.31 0.16,4.72 
Nuclear Fuel 
177 X Services Jablon USA M 0-19 County 19 16 12.41 1.29 0.74,2.09 
Nuclear Fuel 
178 X Services Jablon USA M 0-9 County 19 8 6.78 1.18 0.51,2.32 
179 X Oak Ridge Jablon USA M 0-19 County 35 48 38.68 1.24 0.91,1.65 
180 X Oak Ridge Jablon USA M 0-9 County 35 33 24.63 1.34 0.92,1.88 
181 X Oconee Jablon USA M 0-19 County 12 6 8.44 0.71 0.26,1.55 
182 X Oconee Jablon USA M 0-9 County 12 2 4 0.5 0.06,1.81 
183 X Oyster Creek Jablon USA M 0-19 County 16 23 28.5 0.81 0.51, 1.21 
184 X Oyster Creek Jablon USA M 0-9 County 16 10 15.63 0.64 0.31,1.18 
185 X Paducah Jablon USA M 0-19 County 35 18 20.55 0.88 0.52,1.38 
186 X Paducah Jablon USA M 0-9 County 35 9 12.86 0.7 0.32,1.33 
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187 X Palisades Jablon USA M 0-19 County 14 5 2.82 1.77 0.58,4.14 
188 X Pathfinder Jablon USA M 0-19 County 21 13 19.24 0.68 0.36,1.16 
189 X Pathfinder Jablon USA M 0-9 County 21 6 10.91 0.55 0.2,1.2 
190 X Peach Bottom Jablon USA M 0-19 County 11 37 38.67 0.96 0.67,1.32 
191 X Peach Bottom Jablon USA M 0-9 County 11 21 18.92 1.11 0.69,1.7 
192 X Pilgrim Jablon USA M 0-19 County 13 29 32.52 0.89 0.6,1.28 
193 X Pilgrim Jablon USA M 0-9 County 13 16 16.67 0.96 0.55,1.56 
Point Beachl 
194 X Kewaunee ~ablon USA M 0-19 County 15 10 10.43 0.96 0.46,1.76 
Point Beach! 
195 X Kewaunee Jablon USA M 0-9 County 15 5 5.38 0.93 0.3,2.17 
196 X Portsmouth Jablon USA M 0-19 County 33 4 7.11 0.56 0.15,1.44 
197 X Portsmouth Jablon USA M 0-9 County 33 2 4.44 0.45 0.05, 1.63 
198 X Prarie Island Jablon USA M 0-19 County 12 6 5.02 1.2 0.44,2.6 
199 X Prarie Island Jablon USA M 0-9 County 12 2 2.41 0.83 0.1,3 
200 X Quad Cities Jablon USA M 0-19 County 13 15 18.13 0.83 0.46, 1.36 
201 X Quad Cities Jablon USA M 0-9 County 13 12 9.3 1.29 0.67,2.25 
202 X Rancho Seco Jablon USA M 0-19 County 11 85 63.4 1.34 1.07, 1.66 
203 X Rancho Seeo Jablon USA M 0-9 County 11 47 30.92 1.52 1.12,2.02 
204 X Robinson Jablon USA M 0-19 County 15 12 9.27 1.29 0.67,2.26 
205 X Robinson Jablon USA M 0-9 County 15 6 4.76 1.26 0.46,2.74 
206 X Rocky_ Flats Jablon USA M 0-19 County 32 108 104.02 1.04 0.85,1.25 
207 X Rocky Flats Jablon USA M 0-9 County 32 63 61.17 1.03 0.79,1.32 I 




Salem Jablon USA M 0-9 County 9 5 9.26 0.54 0.18,1.26 
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210 X San Onofre Jablon USA M 0-19 County 18 400 406.36 0.98 0.89,1.09 
211 X San Onofre Jablon USA M 0-9 County 18 229 212.04 1.08 0.94,1.23 
212 X Savannah River Jablon USA M 0-19 County 35 31 42.32 0.73 0.5, 1.04 
213 X Savannah River Jablon USA M 0-9 County 35 21 25.93 0.81 0.5,1.24 
214 X Sequoyah Jablon USA M 0-19 County 5 9 5.25 1.71 0.78,3.25 
215 X Sequoyah Jablon USA M 0-9 County 5 4 2.45 1.63 0.44,4.18 
Shipping Port! 
216 X Beaver Valley Jablon USA M 0-19 County 28 65 61.86 1.05 0.81, 1.34 
Shipping Port! 
217 X Beaver Valley Jablon USA M 0-9 County 28 41 37.61 1.09 0.78,1.48 
218 X St Lucie Jablon USA M 0-19 County 9 3 3.42 0.88 0.18,2.56 
219 X St Lucie Jablon USA M 0-9 County 9 2 1.72 1.16 0.14,4.2 
220 X Surry Jablon USA M 0-19 County 13 2 1.91 1.05 0.13,3.78 
221 X Surry Jablon USA M 0-9· County 13 1 0.9 1.11 0.03,6.19 
222 X Three Mite Island Jablon USA M 0-19 County 11 50 50.44 0.99 0.74,1.31 
223 X Three Mile Island Jablon USA M 0-9 County 11 28 24.56 1.14 0.76,1.65 
224 X Trojan Jablon USA M 0-19 County 10 5 6.14 0.81 0.26,1.9 
225 X Trojan Jablon USA M 0-9 County 10 3 3.16 0.95 0.2,2.77 
226 X Turkey Point Jablon USA M 0-19 County 13 94 96.25 0.98 0.79, 1.2 
227 X Turkey Point Jablon USA M 0-9 County 13 37 46.25 0.8 0.56, 1.1 
228 X lVermont Yankee Jablon USA M 0-19 County 13 6 11.76 0.51 0.19,1.11 
229 X Vermont Yankee Jablon USA M 0-9 County 13 5 5.88 0.85 0.28,1.98 
230 X Yankee Rowe Jablon USA M 0-19 County 25 38 42.65 0.89 0.63,1.22 
231 X Yankee Rowe Jablon USA M 0-9 County 25 20 25 0.8 0.49,1.24 
1232 X Zion Jablon USA M 0-19 County 13 31 45.97 0.67 0.46,0.96 
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233 X Zion Jablon USA M 0-9 County 13 12 22.22 0.54 0.28,0.94 
234 X X 8iblis Kaletsch West Germany 1 0-14 0-15 16 32 30.19 1.06 0.73, 1.5 
235 X X Brokdorf Kaletsch West Germany 1 0-14 0-15 16 4 5.71 0.7 0.19,1.79 
236 X X Brunsbuettel Kaletsch West Germany 1 0-14 0-15 16 3 6.52 0.46 0.09,1.34 
237 X X Grafenrheinf Kaletsch West Germany 1 0-14 0-15 16 16 16 1 0.57, 1.62 
238 X X Grohnde Kaletsch West Germany 1 0-14 0-15 16 7 8.14 0.86 0.35,1.77 
239 X X Gundremmingen Kaletsch West Germany 1 0-14 0-15 16 14 14.29 0.98 0.54, 1.64 
240 X X Hamm Kaletsch West Germany 1 0-14 0-15 16 27 29.03 0.93 0.61, 1.35 
241 X X Juelich Kaletsch West Germany 1 0-14 0-15 16 34 34.34 0.99 0.69,1.38 
242 X X Kahl Kaletsch West Germany 1 0-14 0-15 16 74 71.15 1.04 0.82, 1.31 
243 X X Karlsruhe Kaletsch West Germany J 0-14 0-15 16 39 45.88 0.85 0.6,1.16 
244 X X Kruemmel Kaletsch West Germany I 0-14 0-15 16 16 10.96 1.46 0.83,2.37 
245 X X Lingen Kaletsch West Germany I 0-14 0-15 16 21 18.75 1.12 0.69, 1.71 
246 X X Muelheim-K. Kaletsch West Germany 1 0-14 0-15 16 30 19.11 1.57 1.06,2.24 
247 X X Neckarwestheim Kaletsch West Germany I 0-14 0-15 16 49 46.67 1.05 0.78,1.39 
248 X X Niederaichbach Kaletsch West Germany 1 0-14 0-15 16 15 15 1 0.56, 1.65 
249 X X Obrigheim Kaletsch West Germany 1 0-14 0-15 16 21 16.15 1.3 0.8,1.99 
250 X X Phillippsburg Kaletsch West Germany I 0-14 0-15 16 31 34.83 0.89 0.6, 1.26 
251 X X Stade Kaletsch West Germany I 0-14 0-15 16 15 18.52 0.81 0.45, 1.34 
252 X X Unterweser Kaletsch West Germany I 0-14 0-15 16 19 22.35 0.85 0.51, 1.33 
253 
_. 2_ X Wuergassen Kaletsch West Germany I 0-14 0-15 16 4 7.02 0.57 0.16, 1.46 ------ -------- -----
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A~~endix B - Summar): ofPa~ers Considered for Meta-Anal~sis 
Paper 
(Author, Year} Countr~ Site Age Grou~(s} Area Disease T:y~es Rate Significance? 
0-14 <12.5 kIn 
Leukemia (only), 
COMARE II, 1988 UK Dounreay 
0-24 <25km 




COMARE III, 1989 UK Burghfield, 
0-14 >10km 
Leukemia Incidence Yes 
Aldermaston 




Roman, 1987 UK Burghfield, 
0-14 >15km 
Leukemia Incidence Yes 
Aldermaston 
Baron, 1984 UK 14 sites 0-14 5 miles Leukemia Mortality Yes, for some 
Ewings, 1989 UK Hinkley 0-25 < 12.5 km Leukemia and N on- Incidence Yes 
Hodgkin's Lymphoma 
Bithell, 1994 UK Hinkley 0-14 <25km Leukemia and N on- Incidence No 
Hodgkin's Lymphoma 
Goldsmith, 1992 UK 21 sites 0-9 Leukemia Incidence and Yes, for some Mortality 
Heasman, 1986 UK Dounreay 0-24 
< 12.5 kIn 
Leukemia Incidence Yes 
<25km 
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A~~endix B - continued 
Paper 
{Author, Year} Countr~ Site Age Grou~{s} Area Disease T~~es Rate Significance? 
Cook -Mozaffari, UK Amersham 0-24 < 16km Leukemia Mortality No 
1989 
Bithell, 1994 UK 14 sites 0-14 <25km Leukemia and Non- Incidence Yes, for some 
Hodgkin's Lymphoma 
Cook-Mozaffari, UK 14 sites 0-24 10km Leukemia Mortality Yes, for some 
1988 ALL 
Sofer, 1991 Israel 
Dimona(the 0-9 < 45 km (east) Leukemia 
Incidence No 
Negev) 0-24 < 30 km (west) ALL 
0-4 
Incidence and 





0-4 postal codes 
Leukemia, Incidence and 
(BMJ) 
Canada 5 regions 5-9 and labor force 
ALLandAML Mortality 
No 
10-14 data or 
<25km 
Iwasaki, 1995 Japan 18 sites 0-14 Municipality Leukemia Mortality No 
Lopez-Abente, 1999 Spain 12 sites 0-24 <30km Leukemia Mortality Yes, for some 
<5km 
Hattchouel, 1994 France 13 sites 0-24 
5-10 km 




A~~endix B - continued 
Paper 
{Author, Year) CountrI Site Age Grou~{s) Area Disease TI~es Rate Significance? 
0-4 < 10 km 
Viel, 1990 France La Hague 5-14 <20 Ian Leukemia Mortality No 
15-24 <30km 
0-4 < 10km Yes (0-4 years, 
Viel, 1993 France La Hague 5-14 10-20 kIn Leukemia Incidence 




Dousset, 1989 France 
Hague 
5-14 "Canton" Leukemia Mortality No 
15-24 
0-4 < 10 km 
Viel, 1995 France La Hague 5-14 10-20 Ian Leukemia Incidence No 
15-24 20-35 Ian 
<5km 
Hill," 1990 France La Hague 0-24 
5-10 km 
Leukemia Mortality No 
10-13 km 
13-16 Ian 
Grosche, 1992 Gennany Kruemmel 0-14 Village Leukemia Incidence Yes 
Rossendorf <5km 
Mohner, 1993 Germany Rheinsberg 0-14 5-10 Ian Leukemia Incidence No 
Greifswald 10-15 km 




Acute Leukemia leukemias < 5) 
Kaatsch, 1998 Germany 20 sites 0-14 < 15 km 
Leukemia Incidence No 
Acute Leukemia 
166 
A~~endix B - continued 
Paper 
(Author, Year) CountrI Site Age Grou~(s) Area Disease TI~es Rate Significance? 
Hoffman, 1997 Gennany Kruemmel 0-14 <5km Leukemia Incidence Yes 
Savannah River 
Counties: 
Grosche, 1999 USA 
Region 
0-14 10 in SC Leukemia Incidence No 
12 in GA 
Mangano, 2003 USA 38 sites 0-9 < 30 miles Leukemia Incidence and Yes 
Mortality 
Jablon, 1990 USA 100+ sites 0-9 County Leukemia Incidence and Yes for some 
0-19 Mortality SIR 
Waller, 1995 Sweden 4 sites 0-14 <25km Leukemia Incidence No 
Zaridze, 1994 Kazakhstan 
MUltiple test 
0-14 < 200 km Acute Leukemia N/A Yes, for some 
sites 
Torok, 2002 Hungary 
Response from 
0-14 Country Leukemia Incidence No 
Chemobyl 
Gapanovich, 2001 Belarus 
Response from 
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